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SUMMARY 
 
Autoantigen-specific encephalitogenic T cells exist in the healthy immune repertoire. In case 
of CNS autoimmunity, such as multiple sclerosis (MS), cells penetrate into the central 
nervous system (CNS), where they get activated by local antigen presenting cells, and induce 
inflammation. However, the triggering mechanisms that provoke CNS infiltration of pre-
existing autoreactive T cells are largely unknown. 
Recent studies have shown evidence that microbiota induce proliferation of 
encephalitogenic T cells in gut associated lymphatic tissues (GALT) before CNS infiltration in 
the spontaneous experimental autoimmune encephalomyelitis (EAE), an animal model of 
MS. In this study, the activation and subsequent behaviour of encephalitogenic T cells in the 
GALT are investigated. Myelin oligodendrocyte glycoprotein (MOG) specific T cells from 
transgenic mice are retrovirally transduced with FRET-based calcium activation sensors and 
adoptively transferred to recipient mice. T cells in the lamina propria and Peyer’s patches 
are imaged in vivo with two-photon microscopy and the calcium fluctuation is quantified to 
detect T cell activation. Moreover, migrating T cells in the efferent lymphatic vessels of GALT 
were analysed in order to elucidate phenotypic changes due to in vivo stimulation.  
Intravital imaging reveals that encephalitogenic T cells, but not polyclonal T cells, display 
continuous calcium signaling in the lamina propria. In contrast, encephalitogenic T cells in 
the Peyer’s patch show only brief calcium signaling. The continuous calcium signaling is 
diminished by administration of anti-MHC class II blocking antibody. This observation 
suggests that the calcium signaling of encephalitogenic T cells is mediated by antigen 
presenting cells. Additionally, the role of commensal microbiota is highlighted through the 
fact encephalitogenic T cells do not show continuous calcium signaling in germ free mice, 
which suggests the influence of microbiota.  
The increased number of IL17A and IFNγ producing T cells were detected in efferent lymph 
from mesenteric lymph nodes, further suggests the stimulation of T cells in the GALT. This 
phenotype, in addition to the enhanced number of CD44+ encephalitogenic T cells, suggests 
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that microbiota induced stimulation in the GALT influences the migration of 
encephalitogenic T cells in CNS autoimmunity. 
In summary, the following study reveals pre-existing encephalitogenic T cells are capable of 
being stimulated in the lamina propria of ileum. The stimulation is dependent upon an intact 
gut microbiota compartment and may enhance migration of encephalitogenic T cells.  
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ZUSAMMENFASSUNG  
 
Autoantigen-spezifische enzephalitogene T-Zellen gehören zum Repertoire des gesunden 
Immunsystems. Bisherige Erkenntnisse legen nahe, dass diese Zellen ins Zentrale 
Nervensystem (ZNS) einwandern, wo sie von lokalen Antigen-präsentierenden Zellen 
aktiviert  werden und Entzündungen auslösen, die in Autoimmunerkrankungen wie der 
Multiplen Sklerose (MS) resultieren. Dennoch ist der Mechanismus, wie die ZNS-Infiltration 
der bereits bestehenden autoreaktiven T-Zellen ausgelöst wird, weitgehend unbekannt. 
Neueste Studien zeigen mithilfe der spontanen experimentellen autoimmunen 
Enzephalomyelitis (EAE), einem Tiermodell für MS, dass Mirkobiota die Proliferation von 
enzephalitogenen T-Zellen im Darm-assoziierten lymphatischen Gewebe (GALT)  auslösen 
und eine darauffolgende Einwanderung ins ZNS stattfindet.  
In der vorliegenden Arbeit wurden das Verhalten und die Aktivierung von enzephalitogenen 
T-Zellen im GALT untersucht. Mithilfe eines FRET-basierten Calcium-sensitiven Proteins 
wurde die T-Zell-Aktivierung im Zwei-Photonen-Mikroskop beobachtet. MOG-spezifische T-
Zellen von transgenen Mäusen wurden retroviral mit Aktivierungssensoren transduziert und 
in Empfänger-Mäuse injiziert. Die T-Zellen wurden in der Lamina Propria und in den Peyer-
Plaques in vivo mikroskopiert und deren Calcium-Schwankungen ausgewertet. Des Weiteren 
wurden T-Zellen aus den efferenten lymphatischen Gefäßen des GALT analysiert, um 
phänotypische Veränderungen von auswandernden T-Zellen zu bestimmen.  
Die Zwei-Photonen-Mikroskopie ergab, dass enzephalitogene, nicht jedoch polyklonale T-
Zellen in der Lamina propria kontinuierliche Calcium-Signalgebung  aufweisen. Im Gegensatz 
dazu zeigen T-Zellen in den Peyer-Plaques nur kurze Calcium-Signale. Die kontinuierlich 
hohen Calcium-Levels konnten durch die Verabreichung von MHC-II-blockierenden 
Antikörpern reduziert werden. Diese Beobachtung deutet darauf hin, dass die Calcium-
Signalgebung durch Antigen-präsentierende Zellen ausgelöst wird. Dass die 
enzephalitogenen T-Zellen ebenfalls keine anhaltend erhöhten Calcium-Levels in keimfreien 
Mäusen zeigten, deutet auf den Einfluss der Mikrobiota hin.  
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Dass eine erhöhte Anzahl an IL17A- und IFNγ-prduzierenden T-Zellen in der efferenten 
Lymphe der mesenterischen Lymphknoten detektiert wurde, weist auf die Stimulation von 
T-Zellen im GALT hin. Zusammen mit der erhöhten Expression von CD44 an der Oberfläche 
von enzephalitogenen T-Zellen deuten diese Erkenntnisse darauf hin, dass die Auslösbarkeit 
der Migration von selbstreaktiven T-Zellen ins ZNS im GALT initiiert wird.  
Diese Arbeit zeigt, dass bereits existierende enzephalitogene T-Zellen in der Lamina propria 
des Ileums durch Mikrobiota stimuliert werden und dass dies die Migrationsfähigkeit der T-
Zellen erhöht.  
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INTRODUCTION 
1.1 Multiple Sclerosis 
Multiple sclerosis (MS) is the most frequent chronic autoimmune disease in the central 
nervous system (CNS), which is characterized by demyelination, axonal damage and 
neurodegeneration, accompanying local inflammation (Patejdl and Zettl 2017). There are 
approximately 2.5 million people worldwide afflicted with MS (Flachenecker and Stuke 
2008). The disease is fairly common in white caucasians of northern European ancestry. The 
prevalence in the Nordic region, the British Isles and Canada is ≥ 220 in 100,000 (Rivera 
2017). In the United States, at least 350,000 individuals are affected by MS (Sospedra and 
Martin 2005). The prevalence of MS in Asia has been low but keeps increasing (Eskandarieh, 
Heydarpour et al. 2016). By 2007, the prevalence rate of MS in Shanghai, China, has been 
reported to be 1.39 in 100,000 (Cheng, Miao et al. 2007). The disease affects women about 
twice as often as men. The average age of disease onset is 30-years-old. 25 years after 
diagnosis, approximately 50% of patients require permanent use of a wheelchair (Dendrou, 
Fugger et al. 2015). Therefore, MS has posed a major personal and socioeconomic burden.  
MS has variable clinical courses which include the relapsing remitting form of multiple 
sclerosis (RRMS), primary progressive multiple sclerosis (PPMS) and secondary progressive 
multiple sclerosis (SPMS) (Correale, Gaitan et al. 2017, Patejdl and Zettl 2017). About 15% of 
MS patients show remaining progression of the disease, which is named PPMS (Lublin and 
Reingold 1996). However, even most of patients can completely or partially recover from 
the clinical symptoms, after 10-15 years from the onset, the disease can deteriorate 
progressively and recur, defined as SPMS (Correale, Gaitan et al. 2017). Patients with MS 
can present different clinical symptoms including motor impairment, visual disturbance, 
cognitive impairment and etc.. The variation in clinical manifestations correlates with 
spatiotemporal dissemination of lesion sites in the CNS (Dendrou, Fugger et al. 2015). MS 
lesions have been found both in the cerebral cortex and the deep grey matter of the brain 
(Kidd, Barkhof et al. 1999, Vercellino, Masera et al. 2009).  There are three forms of cortical 
lesions in MS: cortico-subcortical lesions, small intra-cortical lesions and subpial lesions (Bo, 
Vedeler et al. 2003). For the demyelinating lesions in the deep grey matter, nuclei are 
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affected not only by focal plaques of demyelination, but also by diffuse neuronal loss in the 
absence of demyelinated lesions (Cifelli, Arridge et al. 2002, Lassmann 2014).  
Although the pathological mechanisms of MS are not fully clarified, it has been widely 
recognized that brain autoreactive T cells play a critical role during the development of 
disease (Wekerle 2017). Even the CNS has immunological privilege that can prevent the 
infiltration of most peripheral immune cells, it is not without any exception. Once 
autoimmune T cells that pre-exist in the periphery, are stimulated, some of them are able to 
cross the blood brain barrier (BBB) and infiltrate into CNS. These autoreactive T cells which 
scan the CNS and eventually respond to the local antigenic tissue, initiate a cascade of 
inflammatory events including the recruitment of monocytes and B cells (Wekerle 2017). 
There are different subsets of autoimmune T cells possibly mediating the progression of MS, 
among which CD4+ T cells have been concerned as a key player for years. Several studies 
indirectly support the involvement of CD4+ T cells in MS pathogenesis. First, autoreactive 
CD4+ T cells exit in both MS patients and healthy donors (Sospedra and Martin 2005, Pilli, 
Zou et al. 2017). The autoreactive T cells recognize myelin basic protein (MBP) (Pette, Fujita 
et al. 1990, Valli, Sette et al. 1993), myelin associated glycoprotein (MAG) (Andersson, Yu et 
al. 2002) and MOG (Zhang, Markovic-Plese et al. 1994) through HLA binding (Blum, Wearsch 
et al. 2013). Second, myelin-reactive CD4+ T cells in MS patients are functionally different 
from those in healthy controls, with higher expression of IFNγ and IL17 (Olsson, Sun et al. 
1992, Pelfrey, Rudick et al. 2000). Third, genomic studies showed that many MS-associated 
genes, such as HLA-DRB1*1501, are involved in the activation and regulation of CD4+ T cells 
(Sawcer, Franklin et al. 2014).  
Additionally, experimental autoimmune encephalomyelitis (EAE), which is a T cell mediated 
disease model, has been established to study the pathology of MS. In a transgenic mouse 
model, EAE is spontaneously developed due to the expression of a human myelin-antigen-
specific T cell receptor (TCR) together with the matching human HLA class II molecule 
(Madsen, Andersson et al. 1999, Ellmerich, Mycko et al. 2005). CD4+ T cells can be 
differentiated to different subtypes according to their cytokine profile. Among them, IFNγ 
producing Th1 cells have been considered as encephalitogenic T cells (Ando, Clayton et al. 
1989, Merrill, Kono et al. 1992). IL17 producing Th17 cells are firstly described as a new 
lineage of T helper cell lineages in 2005 (Park, Li et al. 2005). Later, Th17 cells are detected 
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in active areas of MS lesions (Tzartos, Friese et al. 2008). Recently, Th17 cells have been 
identified as a pathogenic effector in CNS autoimmune disease (Zepp, Wu et al. 2011, Sie, 
Korn et al. 2014). BBB endothelial cells have been demonstrated to express IL17 and IL22 
receptors in MS lesions, and BBB tight junctions can be disrupted by IL17 and IL22 both in 
vitro and in vivo (Kebir, Kreymborg et al. 2007). Th17 cells can infiltrate into the CNS to 
damage neurons and recruit more CD4+ lymphocytes (Kebir, Kreymborg et al. 2007). Studies 
of EAE provide more evidence about the pathogenic role of Th17 cells in CNS autoimmune 
inflammation. Th17 cells increase significantly in the presence of IL23 in the spinal cord 
during EAE induction (Hirota, Duarte et al. 2011). Administration of anti-IL17 blocking 
antibody after immunization reduced the EAE incidence in mice (Park, Li et al. 2005). 
Furthermore, mice adoptively transferred Th17 polarized MOG-specific CD4+ T cells can 
develop EAE, which indicates Th17 cells involve in the pathogenesis of CNS autoimmune 
inflammation (Jager, Dardalhon et al. 2009). However, how Th17 cells mediate CNS 
autoimmune inflammation is still being investigated. Taken together, these results indicate 
that T h17 cells significantly contribute to EAE/MS pathogenesis. 
Up to date, therapeutic strategies for MS mainly include anti-inflammation, neuroprotection 
and repair-promoting. Anti-inflammatory strategies, such as applying IFNβ1, fingolimod, 
anti-α4 integrin and anti-CD20 antibody, rather benefit the patients of younger age, shorter 
disease duration and ongoing inflammatory lesion activity (Ontaneda, Thompson et al. 
2017). The efficacy of most anti-inflammatory strategies has been demonstrated in RRMS 
and recently in SPMS. For example, IFNβ1-targeted therapies were applied to several clinical 
trials of SPMS. However, only two trials showed positive results while others were negative 
(Li, Zhao et al. 2001, Cohen, Cutter et al. 2002, Andersen, Elovaara et al. 2004, Panitch, 
Miller et al. 2004, Wolinsky, Narayana et al. 2007). An analysis latterly figured out that 
participants with recent relapse activity are more likely to be benefited from the IFNβ1 
treatment (Kappos, Weinshenker et al. 2004). Neuroprotective strategies, including the 
application of simvastatin, phenytoin, cannabinoids and vitamin, also show varying results 
on the disease course. For example, phenytoin, a repurposed sodium-channel blocker, can 
protect axons from inflammatory injury in acute optic neuritis. Treatment with phenytoin 
within two weeks after onset shows a 30% reduction of retinal nerve fiber layer loss 
compared with placebo (Raftopoulos, Hickman et al. 2016). In contrast, another sodium 
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channel blocker, lamotrigine, provides negative results on rescuing cerebral volume loss in 
SPMS (Kapoor, Furby et al. 2010). The disparity may be due to a ‘pseudo-atrophy’ effect 
observed in the first year of lamotrigine study, which may obscure potential benefits 
(Ontaneda, Thompson et al. 2017). Nowadays, repair-promoting strategy is also highly 
noticed in MS treatment. For example, LINGO-1 expressed in the oligodendrocytes and 
neurons impedes remyelination (Mi, Pepinsky et al. 2013). Anti-LINGO-1 blocking antibody 
can promote remyelination in acute optic neuritis (Cadavid, Balcer et al. 2017). However, 
treatment of RRMS and SPMS with anti-LINGO-1 blocking antibody does not improve the 
disability of the patients (Clinicaltrials.gov identifier NCT01864148). Recently, as a potential 
therapy for progressive MS, cell-based repair-promotion draws attention. Windrem and 
colleagues find that hypomyelinating shiverer mice remyelinate and recover from clinical 
phenotype after neonatal transplantation of glial progenitor cells isolated from fetal human 
brain (Windrem, Schanz et al. 2008). Mesenchymal stem cells are also a promising candidate 
for repair-promotion, since they exhibit numerous immunomodulatory and tissue-
protective properties in animal model of MS (Cohen 2013). However, future trials need to 
provide more definitive evidence concerning safety and efficacy. Moreover, important 
methodological questions still remain, including the preferred source, optimal cell 
production protocols and dosing schedules as well as routes of administration. (Ontaneda, 
Thompson et al. 2017).   
 
1.2 Experimental Autoimmune Encephalomyelitis 
There is a complex interaction between immunopathological and neuropathological 
mechanisms involved in MS that is impossible to be fully illuminated by any single clinical 
trial. Therefore, EAE has primarily served as an animal model of human MS. Although none 
of the existing EAE models perfectly reflects the entire MS pathology, each variant of EAE 
resembles some pathological features of MS. EAE was first described by Rivers and 
colleagues over 80 years ago to understand the pathogenesis of the post-vaccinal 
encephalomyelitis (Rivers, Sprunt et al. 1933) and is increasingly used for studying 
pathogenesis and therapeutics of autoimmune diseases. Moreover, immunology and 
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neurobiology based interventions in EAE have been evaluated to explore novel therapies of 
MS (Krishnamoorthy and Wekerle 2009, Constantinescu, Farooqi et al. 2011).  
There are several methods to establish EAE animal models. Immunization with CNS 
homogenates or myelin proteins such MBP, proteolipid protein (PLP) and MOG, through the 
auxiliary of Complete Freund’s Adjuvant (CFA), has been used intensively as the active EAE 
induction (Pender, Tabi et al. 1995, Storch, Stefferl et al. 1998, Stromnes and Goverman 
2006). An important difference between active EAE and human MS is that autoreactive T 
cells in active EAE models are primed and activated by identified antigens whereas triggers 
of human MS are still unclear (Constantinescu, Farooqi et al. 2011). Alternatively, EAE can 
be induced by adoptive transfer of in vitro activated encephalitogenic T cells (Ben-Nun, 
Wekerle et al. 1981). Adoptive transfer EAE is appropriate to study the role of brain 
autoreactive T cells in CNS inflammation (Kawakami, Lassmann et al. 2004, Bartholomaus, 
Kawakami et al. 2009). However, it is still insufficient to study the spontaneity of the disease 
(Gold, Linington et al. 2006). More recently, spontaneous EAE models have been developed 
with transgenic mice. Transgenic mice expressing MBP or MOG specific TCRs, develop EAE in 
the absence of identified antigen sensitization (Goverman, Woods et al. 1993, 
Krishnamoorthy, Saxena et al. 2009). Therefore, spontaneous EAE models are more suitable 
for investigating the triggers of human MS.   
1.2.1 Spontaneous EAE Mouse Model 
Spontaneous EAE models have great advantages to investigate the natural triggering of 
autoimmunity compared with traditional induced EAE models. Neither myelin antigen 
immunization nor external encephalitogenic T cells but pre-existing endogenous 
encephalitogenic T cells are required for the EAE induction. The transgenic 2D2 mouse line 
expresses a TCR reactive to MOG 35-55. 2D2 mice develops optic neuritis with an incident 
rate of 35%, and EAE in 4% of the mice without immunization with myelin antigen (Table 
1.2.1 adopted from (Bettelli, Pagany et al. 2003)). Splenocytes from 2D2 mice rather 
resemble the Th1 cell phenotype by expressing high levels of IFNγ when they are in vitro 
activated by MOG 35-55 peptides (Bettelli, Pagany et al. 2003). Later, the 2D2 mice are 
crossed to transgenic mice with MOG specific Ig heavy chain knock-in B cells 
(Krishnamoorthy, Lassmann et al. 2006). The double transgenic offspring, named OSE mouse, 
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shows higher EAE incidence which is up to 60% (Bettelli, Baeten et al. 2006, Krishnamoorthy, 
Lassmann et al. 2006).  
 
 
 
 
 
 
 
Table 1.2.1 Spontaneous autoimmune diseases in 2D2 TCR transgenic mice. a72 TCR transgenic mice were 
tracked for EAE.  bAmong transgenic mice without EAE, 37 displayed clinical signs of optic neuritis. c15 
transgenic mice were investigated by histology. Group A: mice that presented spontaneous clinical EAE (n=3); 
Group B: mice that never presented signs of EAE. Adopted from (Bettelli, Pagany et al. 2003). 
 
TCR1640 mice, expressing TCR specific for MOG 92-106 on SJL/J background, can also 
develop spontaneous EAE without antigen immunization. However, different from 2D2 mice 
which shows chronic EAE, TCR1640 mice are described to present relapsing remitting EAE at 
a high frequency without genetic modification of B cells (Pollinger, Krishnamoorthy et al. 
2009). In EAE presented TCR1640 mice, there is a significant expansion of MOG reactive B 
cells from the endogenous compartment. Histological analysis shows the deposition of anti-
MOG Ig and infiltration of B cells into spinal cord of the ailing TCR1640 mice (Pollinger, 
Krishnamoorthy et al. 2009). 
 
1.3 Intestinal Immune System and Encephalomyelitis 
1.3.1 Gut Associated Lymphoid Tissue  
The gut contains the small and the large intestine forming a continuous tube that a single 
layer of columnar epithelium lines internally. The small intestine begins at the pylorus, 
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successively constituted by duodenum, jejunum and ileum then terminating at the 
ileocaecal valve. The large intestine is divided to four segments, with the proximal colon 
close to caecum, the transverse colon, the distal colon and ends at the anus (Mowat and 
Agace 2014). The small intestine is anatomically characterized by finger-like projections 
extended in to lumen, known as villi. In the intestinal mucosa, lamina propria is the loosely 
packed connective tissue between epithelium and muscularis mucosa, containing blood 
supply, lymph drainage and nervous provision. Large number and variety of immune cells, 
such as T cells, B cells and innate immune cells, distribute and patrol throughout the laminar 
propria, where majority of immunological events happens (Mowat and Agace 2014, Faria, 
Reis et al. 2017).  
Other well characterized lymphoid structures in the GALT include Peyer’s patches, caecal 
patches and colonic patches. Peyer’s patches, comprised of B cell lymphoid follicles and 
clear T cell zones as similar as lymph node (Cornes 1965), mainly distribute in the ileum of 
the small intestine. In contrast to lymph nodes, Peyer’s patches are not encapsulated, which 
indicates possible responses to luminal antigen. Additionally, Peyer’s patches and colonic 
patches are the main source of intestine-homing IgA plasma blasts and important sites of T 
cell priming (Perry and Sharp 1988, Masahata, Umemoto et al. 2014). Some smaller 
lymphoid aggregates like cryptopatches and isolated lymphoid follicles which are only 
microscopically visible, also play important roles in gut immune events. Distinct from Peyer’s 
patches, isolated lymphoid aggregates primarily consist of B cells, which are implicated as 
essential sites of T cell independent IgA generation (Tsuji, Suzuki et al. 2008, Mowat and 
Agace 2014).  These isolated lymphoid aggregates correlate with the increased microbiota in 
the intestine to maintain intestinal homeostasis (Bouskra, Brezillon et al. 2008). 
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Figure 1.3.1 The immune organs and cells varies along the small intestine. The figure characterized regional 
specialization in the mouse intestine, indicating the variation of antigens (red graphs), GALT (green graphs) 
and leukocyte populations (blue and orange graphs) in frequency along the small intestine. DC, dendritic cell; 
FOXP3, forkhead box P3; IEL, intraepithelial lymphocyte; ILC, innate lymphoid cell; iNKT, invariant natural 
killer T; pDC, plasmacytoid DC; SILT, solitary isolated lymphoid tissue; TH, T helper. (Adopted from Mowat et 
al, 2014) 
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1.3.2 Distribution of Lymphocytes in the Small Intestine 
The Lamina propria and the epithelial layer are the most essential effector sites of the 
intestinal immune system. The lamina propria contains both CD4+ and CD8+ T cells. The 
variety of intestinal CD4+ T cells includes IL10+T regulatory, IFNγ+Th1, IL4+Th2 and IL17+Th17 
subsets (Ivanov, McKenzie et al. 2006, Veenbergen and Samsom 2012, Mowat and Agace 
2014). Th1 and Th2 cells exist throughout the intestine of human without significant 
variation (Wolff, Leung et al. 2012). Th17 cells have been found in the lamina propria of the 
jejunum, ileum, caecum and colon, which show a higher proportion in the ileum and colon 
of humans (Denning, Norris et al. 2011, Sathaliyawala, Kubota et al. 2013). T regulatory cells 
(Tregs) which express both CD4 and Foxp3 also comprise a high proportion of T cells in the 
lamina propria, maintaining the immunological tolerance to the microbiota and dietary 
antigens (Bilate and Lafaille 2012). Moreover, the lamina propria contains a great number of 
IgA and IgM producing plasma cells depending on the presence of GALT microbiota. T cells 
existing in the epithelium can be divided into two subsets. Besides conventional T cells 
mainly expressing an αβ TCR and CD8αβ heterodimer or CD4, unconventional T cells in the 
epithelial layer express CD8αα homodimers and either a γδTCR or an αβTCR (Hayday and 
Gibbons 2008, Cheroutre, Lambolez et al. 2011). 
There are not only lymphocytes, but also a variety of innate immune cells in the intestine. 
Aplenty group 3 innate lymphoid cells (ILC3s) detected in the small intestine express 
effector cytokines and MHC class II molecules in response to gut microbiota, regulating the 
homeostasis of intestinal Th17 cells (Lecuyer, Rakotobe et al. 2014, Longman, Diehl et al. 
2014).  In lamina propria, there are abundant macrophages producing large amount of 
cytokines such as IL10 and IL1β to regulate the activity of T cells (Takeda, Clausen et al. 1999, 
Shaw, Kamada et al. 2012). Four subsets of mouse intestinal dendritic cells have been 
described, including CD103+CD11b+, CD103+CD11b-, CD103-CD11b+ and CD103-CD11b-. 
Among them, CD103+CD11b+ dendritic cells mainly exist in the small intestine, which are 
associated with the presence of Th17 cells through the expression of IL6 (Denning, Norris et 
al. 2011). Figure 1.3.1 shows the distribution of main subsets of immune cells in the small 
intestine. 
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1.3.3 Intestinal Th17 Cells 
Th17 cells are a prominent T cell subset in the lamina propria of the small intestine, 
expressing IL17A, IL17F and IL22 to stimulate intestinal epitheliums to produce mucin and 
antimicrobial proteins (Weaver, Elson et al. 2013). They also mediate the high-affinity 
secretory IgA response of B cells, during the bacteria invasion and colonization (Honda and 
Littman 2016). On the other hand, intestinal Th17 cells also play a pathogenic role in 
aggravating autoimmune diseases by secreting cytokines such as the granulocyte 
macrophage colony-stimulating factor (GM-CSF) which is induced by IL23 from DCs (El-Behi, 
Ciric et al. 2011). It has been well characterized that the differentiation of Th17 cells 
requires the expression of the orphan nuclear receptor RORγt with combination of IL6 and 
TGF-β (Ivanov, McKenzie et al. 2006). There are several studies investigating the impacts of 
environmental factors on intestinal Th17 cells. High salt diet increases the frequency of Th17 
cells in the lamina propria accompanied with more severe EAE in mice (Kleinewietfeld, 
Manzel et al. 2013, Wu, Yosef et al. 2013). The induction of Th17 cells is due to the 
upregulation of serine/threonine-protein kinase Sgk1 (SGK1) which phosphorylates and 
deactivates fork head box protein O1 to aggravate the RORγt-mediated transcription of 
IL17A and IL23 receptor (Kleinewietfeld, Manzel et al. 2013). Long chain fatty acids can 
enhance the expression of IL17A and IFNγ in T cells of the lamina propria by the P38 
phosphorylation and worsen the EAE development (Haghikia, Jorg et al. 2015).  Among the 
environmental factors, microbiota play as the most pivotal role on the induction of Th17 cell 
in the small intestine. Adhesion of segmented filamentous bacteria (SFB) to the intestinal 
epithelium has been related to the accumulation of Th17 cells (Atarashi, Tanoue et al. 2015). 
SFB can upregulate genes of three isoforms of serum amyloid A in the small intestinal 
epithelial cells, in response of which CX3CR1+ myeloid cells produce IL23, IL6 and TGF-β to 
activate ILC3s, enhancing the differentiation of Th17 cells (Atarashi, Tanoue et al. 2015, 
Honda and Littman 2016). Expression of IL17A in RORγt+ cells can also be directly stimulated 
by epithelium-secreted serum amyloid A induced by SFB colonization (Sano, Huang et al. 
2015). Similar induction of Th17 cells has been observed in the monocolonization of C. 
rodentium in germ free mice. Th17 cells proliferate rather than Th1 cells upon the physical 
interaction between the bacteria and epithelial cells. Once the bacteria damage the 
epithelial layer and intrude, massive expression of IFNγ overwhelms IL17A (Atarashi, Tanoue 
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et al. 2015).  Figure1.3.2 shows the details about induction and differentiation of Th17 cell in 
the small intestine.  
 
 
 
 
 
 
 
Figure 1.3.2 Microbiota-mediated induction of Th17 cells and the autoimmunity of Th17 cells in the GALT. 
Adopted from (Honda and Littman 2016) 
 
1.3.4 CD44+CD4+ T cells and Encephalomyelitis 
CD44 is a family of cell surface glycoproteins. It is considered as an adhesion molecule that 
mediates the lymphocyte homing, extravasation and binding to the extracellular matrix 
(Camp, Scheynius et al. 1993, DeGrendele, Estess et al. 1996, DeGrendele, Estess et al. 1997). 
CD44 is widely used as a marker of antigen-experienced T cells and also an activation marker 
implicated in migration (Firan, Dhillon et al. 2006, Alvarez-Sanchez, Cruz-Chamorro et al. 
2015). The most acknowledged function of CD44 is recruiting T cells to inflamed sites 
(Winkler, Foster et al. 2012).    
Recently, CD44 has been reported as an associated factor of EAE development. It has been 
shown that CD44+ activated MBP specific T cells possess the ability to infiltrate into the 
brain of naïve mice (Brocke, Piercy et al. 1999). Both blocking antibody and genetic deletion 
of CD44 can attenuate active EAE in a dose-dependent manner (Brocke, Piercy et al. 1999, 
Guan, Nagarkatti et al. 2011). Lack of the molecule impairs Th1/Th17 polarization (Guan, 
Nagarkatti et al. 2011). Taken together, increased CD44+CD4+ T cells might imply a higher 
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risk of CNS inflammation although the mechanism is still unclear. On the other hand, CD44 
may play a crucial role in alteration of gut microbiome and their metabolism to mediate the 
progress of EAE. CD44 deficient mice exhibit a significant alteration in bacterial 16S 
ribosomal RNA gene sequencing compared with wildtype mice (Chitrala, Guan et al. 2017). 
Fecal transfer from CD44 deficient naïve mice to EAE-induced recipients can lead to 
amelioration of the disease (Chitrala, Guan et al. 2017). How CD44 alters the gut bacteria 
still needs to be further studied. However, until now, there is no direct evidence to relate 
intestinal CD44+CD4+ T cells to the incidence of EAE.  
1.3.5 Gut Microbiota and Encephalomyelitis 
Although the triggers of T cell stimulation in MS and EAE are still indefinite, more and more 
studies draw our attention to the microbiota in the gut. Several studies utilizing the 16S 
ribosomal RNA sequencing have introduced the alterations of the microbiome in MS 
patients compared with healthy controls, as well as in the MS patients on disease modifying 
treatment compared with untreated patients (Chen, Chia et al. 2016, Jangi, Gandhi et al. 
2016). Vitamin D deficiency, smoking and obesity, which are factors involved in MS 
development (Thompson, Baranzini et al. 2018), can also modify the gut microbiome 
composition (Biedermann, Zeitz et al. 2013, Ridaura, Faith et al. 2013, Bashir, Prietl et al. 
2016), raising the question of association between gut microbiota and MS.  
More compelling evidence show the influence of gut microbiota on encephalitogenic T cells. 
In an active EAE model, reduction of bacteria in the gut by oral antibiotic treatment 
attenuates the severity of the disease by alleviation in the global level of pre-inflammation 
(Ochoa-Reparaz, Mielcarz et al. 2009). Another study shows that Gut-CNS immune 
responses during EAE can be aggravated by intestinal microbiota (Lee, Menezes et al. 2011). 
Oral antibiotic administration decreases IL17A and IFNγ producing CD4+ T cells significantly 
in the spinal cord and the lamina propria of the small intestine at the peak of EAE (Lee, 
Menezes et al. 2011). Additionally, the colonization of SFB to germ free restores Th1 and 
Th17 cells during EAE in both the lamina propria of the ileum and the spinal cord (Ivanov, 
Atarashi et al. 2009).  
Spontaneous EAE mouse models provide further evidence that gut microbiota play a crucial 
role in EAE pathogenesis. Transgenic mice that express MBP specific TCR develop 
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spontaneous EAE in the conventional area where some avirulent organisms exist. When 
these transgenic mice are located in the specific pathogen free (SPF) condition, the 
occurrence of EAE decreases significantly (Goverman, Woods et al. 1993). Later, more 
details are clarified in TCR1640 mice which have been introduced as another spontaneous 
EAE model. The TCR1640 mice develop spontaneous EAE with an incidence up to 80% when 
they are kept under SPF condition. Interestingly, when the transgenic mice are housed in 
the germ free environment, EAE incidence is dramatically decreased (Berer, Mues et al. 
2011). The decreased incidence is associated with reduced proliferation of IL17+CD4+ MOG 
specific T cells in the lamina propria and Peyer’s patches of germ free mice (Berer, Mues et 
al. 2011). Another study of MS twins also verifies the influence of microbiota on the disease 
incidence. Monozygotic twin pairs assembled in this study are clinically discordant for MS. In 
each pair, one twin has clinically definite MS whereas the co-twin is unaffected. Germ free 
TCR1640 mice colonized microbiota from MS-twin samples display significantly higher 
incidence of EAE compared with those colonized microbiota from healthy-twin samples 
(Berer, Gerdes et al. 2017). This study provides evidence that MS-derived microbiota can 
precipitate an MS-like autoimmune disease in a spontaneous mouse model. In summary, 
these studies have drawn attention to the impact of microbiota in the GALT on triggering 
MS/EAE. However, mechanisms and the species of microbiota initiating EAE have not been 
fully understood. 
 
1.4 Calcium Dependent T cell Imaging 
1.4.1 Calcium Fluctuation during T cell Activation 
Antigen recognition through TCR engages a variety of signaling cascades, including 
activation of several protein tyrosine kinases, which start the phosphorylation of adaptor 
proteins. This induces the recruitment and activation of the phospholipase PLCγ1. In parallel, 
activation of T cells through binding G-protein-coupled chemokine receptors lead to the 
activation of PLCβ. Then, both PLCβ and PLCγ1 mediate the hydrolysis of the membrane 
phospholipid phosphatidylinositol-4,5-bisphosphate(Ptdlns(4,5)P2) to inositol-1,4,5-
trisphosphate (IP3) and diacylglycerol (DAG) (Fracchia, Pai et al. 2013). IP3 can bind to its 
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receptor on the membrane of the endoplasmic reticulum (ER), triggering the release of 
calcium ions to the cytosol (Feske 2007). Identifying the reduction of calcium ions in the ER, 
stromal interaction molecule 1 (STIM1) on the ER activates calcium-release-activated 
calcium (CRAC) channels within the plasma membrane, causing the rapid increase of 
intracellular Ca2+. Enzymes like calcineurin can be activated in turn by the conformational 
change of calmodulin (CaM) upon binding of cytosolic calcium (Feske 2007, Fracchia, Pai et 
al. 2013). Calcineurin dephosphorylates transcription factors such as nuclear factor of 
activated T cells (NFAT), NF-κB and AP-1 which results in the nuclear translocation of 
transcription complexes and the expression of activation-regulated genes in T cells (Feske, 
Giltnane et al. 2001).  
1.4.2 Twitch2b Calcium Sensor 
Twitch2b is a fluorescence resonance energy transfer (FRET)-based biosensor which can 
identify the activation of T cells via the display of the cytosolic calcium level fluctuation. The 
FRET pair of Twitch2b is composed of the cpVenusCD, a variant of yellow fluorescent protein 
(YFP), and the mCerulean3, a variant of the cyan fluorescent protein (CFP) (Thestrup, 
Litzlbauer et al. 2014). The two variants of fluorescent proteins are connected by a Troponin 
C (TnC) variant which provides a high affinity calcium binding motif (Fig. 1.4.1) (Thestrup, 
Litzlbauer et al. 2014). Twitch2b emits more CFP emission than YFP in lower calcium 
environment. However, in high calcium environment, CFP emission is decreased and YFP 
emission is increased due to conformational changes of Twitch2b as results of calcium 
binding to TnC domain and a subsequent energy transfer from CFP to YFP. (Fig. 1.4.1 A) 
(Thestrup, Litzlbauer et al. 2014).  
Twitch2b possesses several advantages for the intravital imaging of T cells. Compared with 
calcium indicator dyes, the Twitch2b sensor is a genetically encoded calcium indicator that 
can be stably integrated in the genome of target cells, whereas functional calcium indicator 
dyes such as indo-1 can be easily lost during the proliferation of cells. In addition, such 
calcium indicators will be exhausted from T cells within a short time (Sommer, Bischof et al. 
1994, Mues, Bartholomaus et al. 2013). Furthermore, since T cells can change location in the 
three dimensional tissue with high mobility, their brightness changes ceaselessly depending 
on the z-depth of T cells. Therefore, a ratiometric calcium indicator is necessary to normalize 
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this effect (Thestrup, Litzlbauer et al. 2014). GCaMPs, a different kind of genetic activation 
sensors (Tian, Hires et al. 2009), are not designed for ratiometric measurements, since: 1) 
the signal intensity of GCaMPs changes without a spectral shift when calcium concentration 
changes; 2) the peak fluorescence intensity varies with expression levels (Cho, Swanson et al. 
2017). Compared with GCaMPs, FRET-based ratiomeric imaging with the Twitch2b sensor is 
reliable to analyse the activation of lymphocytes, since: 1) it is less affected by changes in 
the optical path length; 2) the excitation light wavelength is fixed 3) it is less impacted by 
expression levels among cells (Thestrup, Litzlbauer et al. 2014). By calculating the ratio of 
YFP divided by CFP as well as the duration of calcium signaling, activation of T cells can be 
identified in real time (Mues, Bartholomaus et al. 2013, Kyratsous, Bauer et al. 2017). 
Compared with Twitch1 and TN-XXL, predecessors of Twitch2b (Mank, Santos et al. 2008), 
Twitch2b is more efficient to bind the cytosolic calcium so that the detection of calcium 
influx is more sensitive and faster. The FRET changes in Twitch2b are optimized after a 
functional screen, which has been highly improved compared with TN-XXL (figure 1.4.1B). 
Furthermore, the brightness of Twitch2b is highly improved allowing better identification of 
expressing cells during in vivo imaging (Thestrup, Litzlbauer et al. 2014).  
1.4.3 NFAT-GFP Sensor 
As it was described previously, elevation of cytosolic calcium is the central event when 
lymphocytes get activated via cell surface receptors and activate calcineurin. Cytosolic NFAT 
is dephosphorylated by the activated calcineurin and then translocate into nucleus to bind 
genomic DNA, inducing the expression of many activation genes in cells. Based on this 
mechanism, the location of NFAT in the cell can be utilized to identify the activation status 
of lymphocytes. For the NFAT-GFP sensor, the DNA binding domain has been mostly 
removed to eliminate the influence on the cell status. GFP is fused to the C-terminal of 
truncated NFAT to show the subcellular localization. This NFAT-GFP sensor has been 
successfully used to visualize the activation of T cells in the spinal cord of the rat transfer 
EAE model (Lodygin, Odoardi et al. 2013, Pesic, Bartholomaus et al. 2013).  Importantly, 
NFAT-GFP and Twitch detect different levels of activation in the cells. Whereas Twitch 
detects antigen independent weak stimulation, only saturated calcium signaling induce 
NFAT-GFP translocation, which is often induced by antigen dependent stimulation 
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(Kyratsous, Bauer et al. 2017). Therefore, the combination of the Twitch and the NFAT-GFP 
sensor provide a detailed view of T cell activation. 
 
 
 
 
 
 
 
 
Figure 1.4.1 Functional characterization of Twitch2b. (A) A schematic of Twitch2b, containing donor 
fluorophore mCerulean3 CFP, cpVenusCD acceptor and calcium-sensitive domain TnC, before (upper) and 
after (lower) binding of calcium.  (B) Alteration in fluorescence ratio of selected Twitch variants in response 
to short-field stimuli eliciting 1–160 action potentials. Response of TN-XXL was taken as comparison. Error 
bars, mean ±s.e.m. (n= 60–204). Modified from (Mues, Bartholomaus et al. 2013, Thestrup, Litzlbauer et al. 
2014) 
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OBJECTIVES 
The one of pivotal events to induce CNS inflammation in the EAE is stimulation of pre-
existing autoreactive T cells in the peripheral tissue. I hypothesize that this priming occurs in 
the GALT. By combining two-photon intravital imaging, fluorescent protein-based activation 
sensors and well established animal model, T cells stimulation in GALT is explored in details 
in this study.  
The first aim of this project is to confirm whether encephalitogenic T cells are stimulated in 
the GALT and to identify the location of the immune-reactive events. A new intravital 
imaging approach needs to be established under the influence of intestinal peristalsis to 
obtain stable movies. By using this method, the calcium signaling and the velocity of 
intestinal T cells must be analysed. To analyse the consequences of T cell stimulation in the 
GALT, phenotypes of encephalitogenic T cells are analysed in the efferent mesenteric lymph. 
The second aim of this project is to investigate how T cells get stimulation in GALT. By 
administration of functional blocking antibodies, the molecular mechanism of calcium 
signaling in T cells can be clarified. Special attention is paid whether the activation of T cells 
in the GALT depends on antigen or not.  
The last aim of this project is to discuss the impact of microbiota on the activation of 
encephalitogenic T cells, since gut microbiota exerts large effects on immune cell 
differentiation and polarization. By transferring the activation sensor labelled T cells to 
recipients housed in germ-free condition, the impact of microbiota involving in T cell 
activation is possible to be illustrated. 
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MATERIAL AND METHODS 
2.1 Material 
2.1.1 Reagents, Medium and Buffer 
Name Constituent   Amount Company 
TCM 
DMEM 1 L Sigma 
L-glutamine 2 mM Sigma 
Penicillin/Streptomycin 
100 IU/ml, 
100 µg/ml 
Sigma 
L-asparagine 0.036 g/L Sigma 
Sodium-Pyruvate 1 mM Sigma 
Non-essential amino acids 10 ml/L Sigma 
2-Mercaptoethanol 4 µl/L Merck 
EH 
DMEM 97.5% Vol Sigma 
HEPES, 1M 2.5% Vol Sigma 
TCM+FCS 
TCM 90% Vol - 
Fetal calf serum 10% Vol Biochrom 
ACK buffer 
NH4Cl 150 mM Sigma 
KHCO3 1 mM Sigma 
EDTA 0.1 mM Merck 
H2O 500 ml - 
RPMI 
RPMI 1640 1 L Sigma 
L-glutamine 2 mM Sigma 
Penicillin/Streptomycin 
100 IU/ml, 
100 µg/ml 
Sigma 
L-asparagine 0.036 g/L Sigma 
Sodium-Pyruvate 1 mM Sigma 
Non-essential amino acids 10 ml/L Sigma 
2-Mercaptoethanol 4 µl/L Merck 
RPMI+FCS TCM 90% Vol - 
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Fetal calf serum 10% Vol Biochrom 
PBS(pH 7.4) 
Na2HPO4 10 mM Sigma 
KH2PO4 1.8 mM Sigma 
NaCl 140 mM VWR international 
KCl 2.7 mM VWR international 
H2O 1 L - 
FACS buffer 
Rat serum 1% Vol - 
PBS 99% Vol - 
EDTA 1 mM Merck 
Sodium azide 0.05 % Vol Sigma 
Freezing medium 
Horse serum 50% Vol Gibco 
EH 40% Vol - 
DMSO 10% Vol Sigma 
2x BES  
(pH 6.95) 
N,N-bis(2-hydroxyethyl)-2-
aminoethanesulfonic acid 
50 mM 
 
Sigma 
NaCl 
280 mM   
 
VWR international 
Na2HPO4 1.5 mM   Merck 
CaCl2 buffer 
CaCl2 2.5 M Sigma 
H2O 50 ml - 
4x Retro/PEG 
(pH 7.4) 
50% PEG6000 320 ml Sigma 
NaCl, 5M 40 ml Sigma 
HEPES, 1M 20 ml Sigma 
H2O 120 ml - 
B220 buffer 
Ca2+ and Mg2+ 
free PBS (pH7.4) 
500 ml Sigma 
BSA 0.1 % Vol Sigma 
EDTA 2mM Merck 
 
Table2.1.1a List of cell culture media, buffers and reagents used in this study. 
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Name Constituent   Amount Company 
LB medium  
Tryptone 10 g Sigma 
Yeast extract 5 g Sigma 
NaCl 5 g VWR international 
H2O 1 L - 
LB agar plate 
Tryptone 10 g Sigma 
Yeast extract 5 g Sigma 
NaCl 5 g VWR international 
Bacto Agar 15 g Merck 
Ampicillin 100 µg/L Sigma 
H2O 1L - 
TAE (pH 8.0) 
Tris-HCl 40 mM Sigma 
Acetic acid 40 mM Sigma 
EDTA 1 mM Merck 
H2O 1L - 
Mouse tail 
lysis buffer 
Tris 100 mM Sigma 
NaCl 120 mM VWR international 
EDTA 5 mM Merck 
Tween 20 0.5% Vol Sigma 
Proteinase K 1mg/ml Genaxxon 
H2O 50 ml - 
DNA loading dye     R0611  Thermo Scientific 
DNA ladder     1kb GeneRuler  Thermo Scientific 
 
Table 2.1.1b List of bacteria growth media, buffers and reagents of DNA works used in this 
study. 
 
 
2.1.2 Cytokines 
Name Store concentration Working concentration Company 
IL2  10 µg/ml 10 ng/ml Peprotech 
IL4 20 µg/ml 1 ng/ml Peprotech 
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IL21 20 µg/ml 10 ng/ ml Peprotech 
 
Table 2.1.2 List of cytokines used in this study 
 
2.1.3 Antibodies 
Antibody  
Clone, Isotype   
Host and specificity  
company 
Applications 
CD3e 
500A2, IgG 
Golden Syrian Hamster anti mouse 
Thermo Fisher 
Cell culture 
CD3 
17A2, IgG2bκ 
Rat anti mouse 
Thermo Fisher 
Flow cytometry 
CD28 
37.51, IgG 
Golden Syrian Hamster anti mouse 
Thermo Fisher 
Cell culture 
TCRβ 
H57-597, IgG 
Armenian Hamster anti mouse 
Thermo Fisher 
Flow cytometry 
CD19 
1D3, IgG2aκ 
Rat anti mouse 
BD 
Flow cytometry 
CD4  
GK1.5, IgG2bκ 
Rat anti mouse 
Thermo Fisher 
Flow cytometry 
CD69 
H1.2F3, IgG 
Armenian Hamster anti mouse 
Thermo Fisher 
Flow cytometry 
IgG1 
A85-1, IgG1κ 
Rat anti mouse 
BD 
Flow cytometry 
IgM 
II/41, IgG2aκ 
Rat anti mouse 
Thermo Fisher 
Flow cytometry 
CD138 
281-2 IgG2aκ 
Rat anti mouse 
BD 
Flow cytometry 
Vα3.2 TCR 
RR3-16, IgG2bκ 
Rat anti mouse 
Thermo Fisher 
Flow cytometry 
Vβ11 TCR 
RR3-15, IgG2bκ 
Rat anti mouse 
Thermo Fisher 
Flow cytometry 
CD25 
PC61.5, IgG1λ 
Rat anti mouse 
Thermo Fisher 
Flow cytometry 
CD44 
IM7, IgG2bκ 
Rat anti mouse 
Biolegend 
Flow cytometry 
IFNγ 
XMG1.2, IgG1κ 
Rat anti mouse 
Thermo Fisher 
Flow cytometry 
IL17A 
TC11-18H10, IgG1κ 
Rat anti mouse 
Biolegend 
Flow cytometry 
MHC class II 
M5/114.115.2, IgG2bκ 
Rat anti mouse 
Biolegend 
Functional 
blocking 
APC IgG Donkey anti Rat 
Jackson Laboratory 
Histology 
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Ep-CAM 
G8.8, IgG2a 
Rat anti mouse 
Santa Cruz 
Histology 
 
Table 2.1.3 List of antibodies used in this study 
 
 
2.1.4 Plasmids 
Name Provider 
pMSCV-∆neo-Twitch2B Thestrup et al., 2014 
pMSCV-∆NFAT-GFP Modified from Pesic et al., 2013 
pCL-Eco Mues et al., 2013  
 
Table 2.1.4 List of plasmids used in this study 
 
2.1.5 PCR Primers 
Recognition Sequence 5’->3’ Expected 
size 
TCR Vα 3.2 
CCC GGG CAA GGC TCA GCC ATG CTC CTG 
675 bp 
GCG GCC GCA ATT CCC AGA GAC ATC CCT CC 
TCR Vα 8.3 
CTC CAT AAG AGC AGC AGC TCC 
700 bp 
CGT CTG TTT CCC ATT CTA AAC TGT ACC 
TCR Vβ 4 
CAA TCT CTG CTT TTG ATG GCT CAA AC 
600 bp 
CTG GAT ATA AAG TCC ACG CAG CC 
Internal positive 
control 
CTA GGC CAC AGA ATT GAA AGA TCT 
324 bp 
GTA GGT GGA AAT TCT AGC ATC ATC C 
 
Table 2.1.5 List of PCR primers used in this study 
 
Oligonucleotide primers were designed with Snap Gene Viewer Version 2.8.3. All 
DNA oligonucleotides were synthesized by Metabion and reconstituted in sterile, 
deionised water to give a stock solution of 100 µM. All the primers used in this 
study have been listed in Table 2.1.5.  
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2.1.6 Animals  
C57BL/6 mice, SJL/J mice, 2D2 mice and TCR1640 mice were obtained from 
Charles River, kept and bred in the animal facility of Max Planck Institute of 
Biochemistry or Biomedical center, LMU. All the animal experiments were 
conducted according to Bavarian state regulations of animal experimentation and 
approved by the appropriate authorities. 
 
Lymphocytes obtained from mice 
Mice were sacrificed and lymphoid tissues were dissected. Single cell suspensions 
were obtained by dissociating tissues through 40 µm cell strainers (BD). Cells were 
collected by centrifugation at 400 g and 4 °C for 5 min for further treatment and 
analysis. 
 
Adoptive transfer of lymphocytes 
Labelled Lymphocytes were re-suspended in 200 µl EH medium and injected to 
each recipient intraperitoneally.  
 
2.2 Methods 
2.2.1 DNA Work 
DNA transformation to bacteria 
5-alpha Competent E. coli cells (NEB) were thawed on ice. 1µl containing 
approximately 50 ng plasmid DNA was added to the competent cell and stirred 
lightly with the pipette tip. The mixture was placed on ice for 30 min then heated 
at 42 °C for 30 sec. Afterwards, 500 µl SOC medium (Sigma) was added to the 
mixture and mixed well. The sample was rotated at 250 rpm in 37 °C for 1 hour. 
After the rotation, the sample was diluted serially in SOC medium and spread 50 
µl onto LB plates, which contains 100 µg/ml ampicillin. LB agar plates were 
incubated in 37 °C overnight. At the second day, the single colony showed on the 
plate was selected for following experiments. 
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Plasmid purification 
DNA plasmids were purified by NucleoBond Xtra Midi or Maxi EF Kit (Macherey-
Nagel) following the manufacture’s instruction. DNA plasmids were eluted by 
endotoxin free stilled H2O and quantitated by Nanodrop ND-2000 (Peqlab).  
 
Mouse tail DNA purification 
Mouse tail biopsies were digested in 500 µl mouse tail buffer with 1 mg/ml 
Proteinase K overnight at 56 °C. After incubation, the sample was centrifuged at 
16000 g and 4 °C for 5 min. The supernatant was transferred to a new Eppendorf 
tube and heated at 95 °C for 10 min to deactivate proteinase K. After cooling 
down, 350 µl of isopropanol was added to the supernatant and mixed gently. The 
mixture was incubated at room temperature for 10 min and then centrifuged at 
16000 g and 4 °C for 10 min. The supernatant was decanted and DNA pellet can be 
observed. The pellet was washed with 1 ml 70% ethanol and centrifuge at 16000 g 
and 4 °C for 5 min. supernatant was removed, the pellet was dried at 56 °C for 10 
min and dissolved in 500 µl H2O.  
 
DNA amplification 
DNA was amplified by polymerase chain reaction (PCR) using DreamTaq green PCR 
master mix (Thermo fisher Scientific). PCR was run by T3-Thermocycler (Biometra) 
according to the instruction of manufacturers. 
 
Agarose gel electrophoresis  
Agarose gel containing 1% agarose in TAE buffer and 1x gelred (Biotium) was used 
to divide different DNA segments. DNA segments in analytical gels were visualized 
in the Geldoc XR system (Bio-Rad) with long wavelength UV light (312 nm). 
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2.2.2 Cell Culture 
Name of cell 
lines 
Provider Origin  
40LB  Krishnamoorthy lab, MPI Nojima et al., 2011 
HEK Kerschensteiner lab, LMU ATCC® CRL-1573 
Phoenix Götz lab, LMU  ATCC® CRL-3215 
 
Freezing and thawing of cell lines 
For preparation of long-term stocks, 10 million cells were harvested and 
suspended with 1 ml freezing medium in a cryotube. Cell stocks were frozen in a 
Cryo 1 °C freezing container (Thermo Fisher Scientific) at -80 °C and subsequently 
stored in liquid nitrogen. For thawing, cell stocks were incubated in 37°C, then 
washed with 10 ml EH medium to remove DMSO. After washing, cells are cultured 
in 10 ml TCM+10%FCS.  
 
Cultivation of cell lines 
Cell lines were cultivated with TMC+10%FCS medium in 10 cm tissue culture 
dishes (Corning) in a humidified incubator (New Brunswick) at 37 °C and 10% CO2. 
Semi-adherent cells, such as Phoenix cells and HEK cells, were harvested by 
flushing off the cell culture dish; whereas adherent cells, such as 40LB cells, were 
treated by Trypsin-EDTA (Sigma) for 5 min at 37 °C and then flushed off. Cells 
were enumerated by a hemocytometer (Neubauer) and pelleted by centrifugation 
at 400 g and 4 °C for 5 min. Cells were subcultured by diluting in fresh 
TCM+10%FCS medium at ratios from 1:3 to 1:5. 
 
Irradiation of cell lines 
40LB Cells were suspended in 20 ml EH medium and exposed to 120 Gy r-radiation 
source. After irradiation, cells were re-suspended in TCM+10%FCS and cultivated 
as description above. 
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Calcium phosphate transfection of phoenix cells 
1.5 Million Phoenix cells were plated to 10 cm culture dish in 10 ml TCM+10%FCS 
and incubated overnight in a humidified incubator at 37 °C and 10% CO2. Next day, 
25 µM chloroquine (Sigma-Aldrich) was added to cells. To prepare transfection 
complex to each dish of cells, 12 µg pMSCV plasmid and 3.5 µg pCL-Eco plasmid 
were dissolved in 450 µl H2O mixed with 50 µl 2.5 M CaCl2, adding 500 µl 2x BES 
dropwise during vortexing. The transfection complex was incubated at 37 °C for 
20 min to form calcium phosphate-DNA co-precipitate then applied onto phoenix 
cells dropwise. After overnight incubation, culture medium was replaced by fresh 
TCM+10%FCS to detoxify cells from calcium phosphate and chloroquine. 
  
PEI transfection of HEK cells 
1.5 Million HEK cells were plated to 10 cm culture dish in 10 ml TCM+10%FCS and 
incubated overnight in a humidified incubator at 37 °C and 10% CO2. To prepare 
transfection complex to each dish of cells, prepare buffer A: 12 µg pMSCV plasmid 
and 3.5 µg pCL-Eco plasmid were dissolved in 500 µl TCM and buffer B: 20 µl 
PEIMax (2 mg/ml) was mixed with 500 µl TCM. After incubation for 5 min, buffer A 
and buffer B were mixed by vortex. The transfection complex was incubated at 
room temperature for 20 min then applied onto HEK cells dropwise. After 
overnight incubation, culture medium was replaced by fresh TCM+10%FCS to 
detoxify cells 
 
Retrovirus collection 
The supernatant of transfected cells was collect 48 hr and 72 hr after transfection 
and filtrated with 0.45 µm filter. There were two methods to prepare the 
concentrated retrovirus stock. First, the supernatant was concentrated with an 
Amicon Ultra 15 ml centrifugal filter (cut-off: 100 KDa, Millipore) at 4000 g and 
4 °C for 20 min. Alternatively, the supernatant was mixed with 4x Retro/PEG 
solution as the ratio 1:3 and stored at 4 °C overnight. At the second day, the 
mixture was centrifuged 1500 g for 30 min at 4 °C to obtain virus pellet. After 
centrifugation, remove supernatant and re-suspend the virus pellet with certain 
volume of TCM medium. The concentrated virus was stored at -80 °C until use. 
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Primary culture and Spin-down retroviral transduction of primary T cells 
Splenocytes and lymph node cells were prepared from C57BL/6 mice, SJL mice, 
2D2 mice and TCR1640 mice. Splenocytes were treated with ACK for 3 min on ice 
to removed erythrocytes. The cells were cultivated at 37 °C and 5% CO2 in 
RPMI+10%FCS medium, 20 millions of cells per well in 6-well tissue cultured plate 
(corning) and stimulated with 0.5 µg/ml anti-CD3e and 0.5 µg/ml anti-CD28 
antibodies. Recombinant murine IL2 was applied to cells as 10 ng/ml at the second 
day. T cells were purified either before the primary culturing or 2 days after the 
culturing. The purification of T cells was followed the instruction of Dynabeads™ 
Mouse Pan B kit (Thermo Fisher Scientific). Two days after the stimulation, 
retroviral transduction was performed for T cells. Obtained T cells were re-
suspended in RPMI+10%FCS medium containing 8 µg/ml polybrene (Sigma) and 10 
ng/ml IL2, mixed with retroviral stock as 5:1 and applied to 12-well no tissue 
cultured plate (Corning) as 2 million in each well with 500 µl medium. The cells 
were spinning down at 2000 g in room temperature for 90 min. After 
centrifugation, 800 µl RPMI+10%FCS medium containing 10 ng/ml IL2 was applied 
to each well of plate. The cells were incubated in a humidified incubator overnight 
at 37 °C and 5% CO2 then analyzed the transduction efficiency by flow cytometry. 
T cells were harvested and counted at the same day of analysis. Number of 
transduced T cells was calculated by the transduction efficiency. 10 Million 
transduced T cells were intravenously transferred to each of the recipients.  
 
Primary B cell culture 
One day before B cell cultivation, 40LB cells, as feeder cell, were irradiated as 
described above and plated as 80% confluence in 10 cm tissue cultured dishes. 
Splenocytes obtained from mice were treated with ACK buffer for 3 min to remove 
erythrocytes. B cells were purified as the instruction of mouse B cell isolation kit 
(Stemcell Technologies) and applied to each dish of 40LB cells as 8x105 cells with 
40 ml RPMI+10%FCS containing 1 ng/ml recombinant murine IL4. The medium was 
refreshed at the second day with 1 ng/ml IL4 in RPMI+10%FCS. After 2-days 
cultivation, B cells were further cultured on irradiated 40LB cells in fresh 
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RPMI+10%FCS containing 10 ng/ml recombinant murine IL21 (Nojima, Haniuda et 
al. 2011).  
 
Retroviral transduction of primary B cells 
At the second day of cultivated in IL21 containing medium, the stimulated B cells 
were harvested for retroviral transduction. B cells were re-suspended in 
RPMI+10%FCS medium containing 8 µg/ml polybrene and 10 ng/ml IL21, mixed 
with retroviral stock as 5:1 and applied to 12-well no tissue cultured plate 
(Corning) as 2 million in each well with 500 µl medium. Cells were centrifuged at 
2000 g for 90 mins in RT. After centrifugation, 800 µl RPMI+10%FCS medium 
containing 10 ng/ml IL21 was added to each well of plate. The cells were 
incubated in a humidified incubator overnight at 37 °C and 5% CO2 then analyzed 
the transduction efficiency by flow cytometry. 
 
Cell labeling with carboxy-fluorescein diacetate succinimidyl ester (CFSE) 
20 Millions of lymphocytes were suspended in 5 ml PBS containing 1% FCS and 2 
µM CFSE (Life technologies) and incubated at 37 °C for 15 min. The falcon tube 
containing cells was filled to 50 ml by cold EH+10%HS medium and incubated on 
ice for 5 min to stop the labeling reaction. Cells were collected by 300 g 
centrifugation at 4 °C for 5 min and washed with cold PBS for once. Then cells 
were re-suspended in EH medium and ready to transfer to the recipients.  
 
2.2.4 Intravital Imaging for the Small Intestine 
Two-photon microscopy 
Time-lapse two-photon laser-scanning microscopy was performed using a SP2 
confocal microscope (Leica) equipped with a 10 W Millenia/Tsunami laser 
(Newport Spectra Physics). Excitation wavelength was tuned to 835nm for 
Twitch2b sensor or 880 nm for NFAT sensor and routed through a 25x water-
immersion objective (N.A. 0.95, Leica). Imaging was done with 2x zoom and 25-35 
µm z-stacks were acquired with 2-3 µm step size. Acquisition rate was 25.219 s 
time interval, with images line-averaged twice. Fluorescent signals were detected 
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using non-descanned photomultiplier tube detectors (Hamamatsu) equipped with 
475/50 (CFP), 525/50 (GFP), 537/26 (FRET) and 630/69 (Tetramethylrhodamine) 
band-pass filters (Semrock). To control the blood flow, 100 µg 
tetramethylrhodamine (molecular weight: 2 MDa) (invitrogen) was intravenously 
injected to each mouse. 
 
Administration of antibodies 
During the intravital imaging, 100 µg blocking antibodies mixed with 100 µg 
tetramethylrhodamine-dextran conjugates (molecular weight: 2 MDa) was 
intravenously injected to each mouse. Tetramethylrhodamine was used to confirm 
that the antibody was successfully transferred.  
 
Image analysis 
Time-lapse images were acquired using Leica LCS software (Leica), and 
subsequently processed and analyzed by ImageJ (NIH). To obtain two-dimensional 
movies, a Gaussian blur filter was applied, the contrast was adjusted by liner 
rescaling, and maximum intensity z-projections were made. Ratiometric 
pseudocolor pictures were generated by dividing the FRET by the CFP channel and 
applying a fire lookup table. For analysis, cell shape at each time point was 
manually outlined in the maximum projection picture, and average signal 
intensities of all pixels within this area were calculated. Motility parameters and 
cell trajectories were calculated from the obtained position coordinates using 
ImageJ.  
 
2.2.5 Histology 
Tissue section 
Fresh organs from mice were fixed in 4% PFA overnight and immerged in 35 % 
sucrose overnight. Tissues were embedded in Tissue-Tec O.C.T. Compound 
(Sakura), and 20 µm sections were cut on a CM3050 S Cryocutter (Leica). The 
sections were stored at -20 °C until use for immunohistochemistry. 
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Fluorescence immunohistochemistry 
Tissue sections were thawed, fixed in 4% PFA for 30 min, and blocked with 1% 
bovine serum albumin in PBS for 1 h at room temperature. This buffer was used 
for all further steps. Incubation with primary antibody (dilution 1:100) was done 
at 4 °C overnight, and with secondary antibody (dilution 1:400) for 1-3 h at room 
temperature. The sections were washed three times, each for 10 min, in between. 
Slides were embedded in Fluoromount-G medium (eBiosicence). Images were 
acquired on an SP8X WLL upright confocal microscope (Leica). Individual images 
were assembled through maximum projection in each channel and then overlaid 
by ImageJ.   
 
2.2.6 Lymphatic Cannulation 
30 min prior to cannulation, 200 µl olive oil was administered by oral gavage to 
identify mesenteric lymphatic vessels that are located just upstream of the 
thoracic duct (Druzd, Matveeva et al. 2017). Mice were anesthetized by 
intraperitoneal injection of fentanyl/midazolam/medetomidine (50 µg/kg, 5mg/kg 
and 500 µg/kg bodyweight, respectively) and lymph was drawn via a fine bore 
polythene tubing (Warner Instruments) that had previously been flushed with PBS 
containing EDTA. Volume of lymphatic solution was recorded and cell numbers 
were determined together with defined amount of FITC conjugated beads by flow 
cytometry. 
 
2.2.7 Flow Cytometry  
Purification of lymphocytes from peripheral blood 
200 µl Blood and 25 µl optiprep (Sigma) were mixed together in an Eppendorf 
tube. 500 µl PBS was applied carefully on top of the mixture. The gradient 
solution was centrifuged at 2000 g for 30 min at room temperature, with mild 
acceleration and no breaking deceleration. The lymphocytes were collected from 
interface. 
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Surface staining  
Lymphocytes obtained from lymph solution or blood were transferred into 96-well 
V-bottom plates (Nunc) and washed with 100 µl FACS buffer by centrifuging at 400 
g for 5 min at 4 °C. Antibodies were diluted as 1:200 in the FACS buffer and 
applied 50 µl per well. After 30 min incubation on ice, cells were washed twice 
with FACS buffer. Lastly, cells were suspended in 100µl PBS and 100 µl FITC 
conjugated beads were added to the cells to re-suspend.  Every washing step 
required a centrifugation at 400 g for 5 min at 4°C. 
 
Intracellular staining 
For intracellular staining, cells were stimulated by PMA (10 µg/ml)/ionomycin (1 
µM) (Sigma) for 2 hr and then incubated in 5 µg/ml Brefeldin A (Sigma) for 
another 2 hr. Then, cells were fixed in 2 % PFA for 20 min on ice. Cells were 
washed in PBS after fixation and then were permeabilized by incubation with 
permeabilization buffer (Thermo Fisher) on ice for 15 min. The primary antibodies 
for IFNγ and IL17A were diluted as 1:200 in the permeabilization buffer and added 
50 µl to each well of cells.  Cells were incubated on ice for 30min. After washing 
twice with permeabilization buffer, cells were resuspended in 100 µl PBS plus 100 
µl FITC conjugated beads.  
All samples were measured by FACS VERSE (BD) and data analysis was performed 
by FlowJo software (FlowJo LLC). 
 
2.2.8 Statistical Analysis 
The statistical evaluation was performed using Prism software (GraphPad). Test 
used, as well as the resulting p value is specified for each experiment separately 
in the figure legends. Significance was indicated according to the p-value as the 
following: NS: no significant, *p<0.05, **p<0.01, ***p<0.001. 
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RESULTS 
3.1 Retroviral Transduction of T cells 
3.1.1 Optimization of Retroviral Transduction of Mouse T cells  
To visualize the real-time activation of T cells in vivo by two-photon microscopy, T cells were 
genetically labelled to express one of two activation sensors. Twitch2b and NFAT-GFP 
expressing transgenic mice are not yet available. Therefore, this study utilizes retroviral 
gene transfer. Previously, by co-culturing with retrovirus producing GP+E86 cells packaged 
retrovirus, rat T cell lines were successfully transduced with NFAT-GFP or Twitch and used to 
visualize real-time activation (Pesic, Bartholomaus et al. 2013, Kyratsous, Bauer et al. 2017).  
Unfortunately, this method does not work well for mouse T cells. For mouse T cells, the 
exposure to high titer retrovirus results in efficient transduction (Mues, Bartholomaus et al. 
2013). This latter method was further optimized as follows: Retrovirus containning 
activation sensors were packaged by transfecting retrovirus plasmid, pMSCV, and packaging 
plasmid, pCL-Eco, to packaging cells, such as Phoenix cells and HEK cells. Initially, different 
transfection methods were evaluated. PEI transfection, but not calcium phosphate 
transfection, of HEK cells allowed for the greatest results. The produced retroviral 
supernatant was subsequently further concentrated to enhance transduction efficiency. 
Retrovirus was concentrated by the Amicon centrifugal filter, as this method presented a 
higher transduction efficiency than precipitation by PEG (Fig.3.1.1).  
In addition, the way in which T cells are cultured in vitro also affected the efficiency of 
retroviral transduction. Therefore, different protocols were explored to maximize retoviral 
transduction. To this end, T cells were purified at different time points, either before T cell 
stimulation with anti-CD3/CD28 antibodies or after stimulation, just before retroviral 
transduction. The best result was obtained when T cells are purified before their stimulation 
(Fig.3.1.1). Combining these methods provided highly efficient transduction, around 12%. 
Therefore, this protocol was applied to all the retroviral transduction cultures in this study. 
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3.1.2 Retroviral Transduction of T Cells with NFAT-GFP 
In the present work, primary cultured T cells were purified after harvested from spleen and 
lymph nodes of wildtype or MOG specific TCR transgenic mice, 2D2 and TCR1640 mice. 
Following stimulation with anti-CD3/CD28 antibodies for 2 days, spin-down transduction 
was performed as described in the methods section. 24 hrs after transduction, transduction 
efficiency was confirmed by flow cytometry. Both polyclonal and 2D2 T cells are successfully 
labelled with NFAT-GFP sensors (Fig. 3.1.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.1 Retroviral transduction efficiency of polyclonal T cells from SJL/J mice under different conditions. 
T cells were purified before or after culturing. Twitch2b coding retrovirus was concentrated by centrifugal 
column or by PEG precipitation. Expression of Twitch2b was analysed 24 hr after transduction. 
Representative results from 2 independent experiments.  
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Figure 3.1.2 Representative flow cytometry histograms of NFAT-GFP expression in T cells. Polyclonal T cells 
or 2D2 T cells were transduced by NFAT-GFP coding retrovirus. Expression of NFAT-GFP was analysed 24 hr 
after transduction. 
 
3.1.3 Retroviral Transduction of T Cells with Twitch2b 
As described above, the Twitch2b sensor delineates the status of T cell activation, through 
visualization of intracellular calcium levels by two photon microscopy (Mues, Bartholomaus 
et al. 2013, Thestrup, Litzlbauer et al. 2014). For this reason, primary cultured mouse T cells 
were genetically labelled by the Twitch2b sensor in the same manner as previously 
described for the NFAT-GFP sensor. Transduction efficiency was analysed by flow cytometry 
24 hrs after the transduction (Fig. 3.1.3). 
 
Figure 3.1.3 Representative flow cytometry histograms of Twitch2b expression in T cells. Polyclonal or 2D2 T 
cells were transduced with Twitch2b coding retrovirus. Expression of Twitch2b was analysed 24 hr after 
transduction. 
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3.2 MOG specific T cells in the GALT 
3.2.1 GALT Infiltration of T cells 
To determine the appropriate time point for intravital imaging of transferred T cells in the 
GALT, lymphocytes labelled with CFSE were transferred to mice in order to explore the 
kinetics of GALT cell infiltration. Mesenteric lymph nodes and Peyer’s patches were 
dissected from recipients at different time points after adoptive transfer. The spleen was 
used as a positive control, as it is known that adoptively transferred T cells migrate 
efficiently there. Since a mixed population of lymphocytes was used for the adoptive 
transfer, infiltrating CFSE-labelled lymphocytes were subsequently stained with anti-CD3 
and CD19 antibodies to identify T cells and B cells respectively. Phenotype was determined 
by flow cytometry analysis and the number of cells was quantified by adding a defined 
number of FITC beads as described in method section.  
The number of T cells in Peyer’s patches was stable from 24 hr to 7 days after injection, 
whereas the number in the mesenteric lymph nodes increased up to 48 hrs until it became 
stable at 7 days after injection (Fig. 3.2.1 A). Based on these results, the third day after 
injection was selected as the time point of imaging T cells in GALT for the following 
experiments. 
The number of B cells continued to increase in both Peyer’s patches and mesenteric lymph 
nodes from 3 hrs to 7 days after cell transfer (Fig. 3.2.1 B). Therefore, intravital imaging of B 
cells in the GALT could be performed at the earliest 7 days after the cells transfer. 
The total number of CFSE labelled lymphocytes infiltrating the GALT was also quantified. 
Generally, the number of lymphocytes constantly increased with time in the Peyer’s patches 
and mesenteric lymph nodes (Fig. 3.2.1 C). 
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Figure 3.2.1 Kinetics of GALT infiltrating lymphocytes. Dynamics of transferred T cells (A), B cells (B) and total 
lymphocytes (C) in the Peyer’s patch (PP), mesenteric lymph node (MLN) and spleen (SP) were analyzed 3 hr, 
24 hr, 48 hr and 7 days after i.v. injection. Each time point/group contains two animals. Results are 
representative of 3 independent experiments. 
 
3.2.2 Establishment of Surgical Setup for Imaging Intestine 
Applying intravital imaging in the intestine is difficult as intestinal peristalsis 
greatly interferes with the stability of the visual field. To overcome this 
chanllenge, a special surgical setup was established in this study. Mice were 
anaesthetized by intraperitoneal injection of fentanyl/midazolam/medetomidine 
(50 µg/kg, 5 mg/kg, and 500 µg/kg bodyweight, respectively), orotracheally 
intubated, and ventilated with 1% isoflurane. Mice were placed on a custom-made 
microscope stage and the body temperature was regulated by a heated pad and 
thermo-sensor (37 °C). Electrocardiograms were recorded and physiological 
parameters, such as concentrations of inspiratory and expiratory gases, and 
ventilation pressure were constantly monitored during imaging. The small 
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intestine was exposed as showing in figure 3.2.2, which was coated with agarose, 
stabilized by tissue adhesive glue (3M Animal Care Products), and a cover slip 
mounted with gentle pressure (Fig. 3.2.2 A). This setup was for imaging the PP 
from the intestinal wall side. For imaging the lamina propria, the lumen side of 
the ileum was exposed by a cautery pen-created incision in order to prevent 
bleeding. Intestinal contents were removed carefully by tutofusin (Baxter) rinsing. 
The lamina propria was stabilized on top of tutofusin buffer rinsed tissue paper 
through surrounding the exposed area with tissue adhesive glue and carefully 
mounting a cover slip. This surgical setup ensures the preservation of both the 
morphology and blood flow of the lamina propria (Fig. 3.2.2 B). In additon, this 
setup is also suitable for imaging Peyer’s patch from lumen side. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.2 Surgical setup for intravital imaging of Peyer’s patches and lamina propria. A. The 
surgical setup for imaging Peyer’s patches from the intestinal wall side. The intestine was 
surrounded by agarose and stabilized by tissue adhesive glue. B. The surgical window for 
imaging both the lamina propria and Peyer’s patches from the lumen side. Tissue adhesion was 
applied at the periphery of the exposed tissue to allow for stabilization without disturbing the 
central area. The pressure used to mount the coverslip on the tissue was regulated by 
adjusting the height of the coverslip.  
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3.2.3 Intravital Imaging of MOG Specific T Cells in the Lamina Propria 
Twitch2b labelled 2D2 T cells were intravenously transferred to wildtype C57BL/6 mice. In 
parallel, Twitch2b labelled polyclonal T cells from C57BL/6 mice were transferred to the 
littermates in order to evaluate the importance of antigen specificity. Intravital imaging of 
the lamina propria was performed 3 days after the adoptive transfer.  
 
Figure 3.2.3 Calcium imaging of T cells in the lamina propria. A and C. Series of pictures shows long calcium 
signaling in a 2D2 T cell (A) and short calcium signaling in a polyclonal T cell (C). The cell of interest is 
indicated with arrows in fluorescent overlay pictures (upper) and outlined in pseudocolour ratio images 
(lower). Blood vessels labelled in red with Rhodamine; T cells labelled in blue/green with Twitch2b; Scale 
bar, 20 µm. B and D. Time course tracking of a representative 2D2 T cell showing long calcium signaling (A) 
and a polyclonal T cell showing short lasting calcium signaling (D). Intracellular calcium fluctuation (red line) 
and velocity (blue line). Gray shadow indicates the time window shown A and C.  
 
The Twitch2b sensor depicts cytosolic calcium levels through quantifying the ratio of 
YFP/CFP fluorescence. Therefore, in order to define calcium signals, it is necessary to set a 
threshold for YFP/CFP. In the present study, the threshold was defined as a ratio of 0.69 
which is a threshold that 95% of the polyclonal T cells in the lamina propria are below. 
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According to this threshold, high calcium signals occurred more frequently in 2D2 T cells 
than in polyclonal T cells in the lamina propria (Fig. 3.2.3). A representative example of 2D2 
T cells showing continuous calcium signaling in the lamina propria of ileum was illustrated 
(Fig. 3.2.3 A and B). In contrast, polyclonal T cells showed only short calcium signaling (Fig. 
3.2.3 C) which lasted typically less than 1 min (Fig. 3.2.3 D).   
 
Figure 3.2.4 Analysis of calcium level and velocity of 2D2 T cells and polyclonal T cells in the lamina propria. 
A. A representative cumulative calcium levels (ratio of YFP/CFP) in 2D2 T cells and polyclonal T cells from 3 
experiments are shown. B. Percentage of high calcium signal in 2D2 T cells and polyclonal T cells. C. A 
representative plot of velocity of 2D2 T cells and polyclonal T cells from 3 experiments is shown. D. Average 
velocity of 2D2 T cells and polyclonal T cells. In A and C, each dot represents the calcium level (A) or velocity 
(C) at a given time point and red lines indicate the mean. In B and D, means ± SEM from three independent 
experiments are shown. Statistical differences were analysed by independent sample T-test.   
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All FRET and motility values from 2D2 and polyclonal T cells were plotted in Fig. 3.2.4. in the 
lamina propria, the ratio values of for YFP/CFP in 2D2 T cells were significantly higher than 
polyclonal T cells (Fig. 3.2.4 A). 2D2 T cells showed high calcium signals more frequently than 
polyclonal T cells (Fig. 3.2.4 B). High calcium signal occurred in 2D2 T cells was around 11%, 
which is 8 times more than in polyclonal T cells (Fig. 3.2.4 B). Additionally, motility of 2D2 T 
cells in lamina propria was slower than motility of the polyclonal T cells (Fig. 3.2.4 C and D).  
The duration of high calcium signal persisting in 2D2 T cells and polyclonal T cells in lamina 
propria was also compared (Fig. 3.2.5). 2D2 T cells presented longer lasting high calcium 
signal in the lamina propria than polyclonal T cells. Several 2D2 T cells showed continuous 
calcium signaling, which suggested that T cells got stimulated in the lamina propria. In 
contrast, most of the calcium signaling shown by polyclonal T cells was shorter than 2 mins 
(Fig. 3.2.5 A).   
 
Figure 3.2.5 Duration of calcium signaling in 2D2 T cells and polyclonal T cells in the lamina propria. A. Each 
cumulative plot represents the duration of calcium signaling in 2D2 or polyclonal T cells. Each dot represents 
a single calcium signaling event. Sum of 3 experiments are shown. B. The propotion of calcium signaling 
duration in 2D2 vs. polyclonal T cells. Mean ± SEM from 3 independent experiments are shown. Statistical 
differences were analysed by independent sample T-test.  
 
In order to extract more details, the duration of calcium signaling was further analysed (Fig. 
3.2.5 B). First, the percentage of T cells with long term high calcium signal (>2 min) was 
analysed. Out of 60 2D2 T cells and 56 polyclonal T cells in the lamina propria from 3 
RESULTS 
45 
 
independent experiments, 19 2D2 T cells (20%) presented continuous calcium signaling 
whereas only one polyclonal T cell presented continuous calcium signaling (Fig. 3.2.5 B). 
Secondly, short calcium signaling (<2min) was analysed. There was no significant difference 
in short calcium signaling between 2D2 T cells and polyclonal T cells (Fig. 3.2.5 B).  However, 
there is a significantly greater number of polyclonal T cells that show no calcium signaling 
(~80%) (Fig. 3.2.5 B). 
 
Figure 3.2.6 Calcium imaging of TCR1640 T cells in the lamina propria. A. Representative images of a 
TCR1640 T cell showing long calcium signaling that lasts around 12 min. Arrows in fluorescent overlay (left) 
and dotted outlines in pseudocolour ratio images (right) indicate a cell of interest. Blood vessels are labelled 
in red with Rhodamine; T cells are labelled in blue/greed with Twitch2b; Scale bar, 10 µm. B. Time course 
tracking of a TCR1640 T cell. Intracellular calcium fluctuation (red line) and velocity (blue line). Gray shadow 
indicates the time window visualized in A.  
In addition to imaging 2D2 T cells, TCR1640 T cells in the lamina propria were also 
investigated by two-photon microscopy. As described above, 2D2 T cells express a TCR that 
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recognizes MOG peptide 35-55, whereas TCR1640 T cells contain a TCR that recognizes 
MOG peptide 92-106. Therefore, probing TCR1640 T cells functionality in the lamina propria 
provides further insight into antigen specificity and T cell stimulation.  
TCR1640 T cells were transduced with Twitch2b coding retrovirus by using the same method 
as 2D2 T cells, and then intravenously transferred to wildtype SJL/J mice. Intravital imaging 
was performed 3 days after the transfer. Similar to 2D2 T cells in C57BL/6 mice, TCR1640 T 
cells show calcium signaling in lamina propria more frequently than polyclonal T cells from 
SJL/J mice (Fig. 3.2.6 and Fig. 3.2.7).  
Calcium signals from TCR1640 and polyclonal T cells were displayed in figure 3.2.7 A. Similar 
to 2D2 T cells, a greater number of TCR1640 T cells were above threshold than polyclonal T 
cells in the lamina propria of ileum (Fig. 3.2.7 A). Furthermore, TCR1640 T cells undergo High 
calcium signals more frequently than polyclonal T cells (Fig. 3.2.7 B). High calcium signal was 
was observed in approximately 14% of TCR1640 T cells – a significantly greater percentage 
than polyclonal T cells (Fig. 3.2.7 B). Additionally, duration of continuous calcium signaling in 
TCR1640 T cells and polyclonal T cells in the lamina propria was analysed (Fig. 3.2.7 C and D). 
Compared with polyclonal T cells, TCR1640 T cells showed longer calcium signaling in the 
lamina propria, suggesting stimulation (Fig. 3.2.7 C). This duration of calcium signaling was 
analysed in further details (Fig. 3.2.7 D). In total, 59 TCR1640 T cells and 59 polyclonal T cells 
in the lamina propria from 3 independent experiments were analysed. Similar to the 
relationship between 2D2 T cells and polyclonal T cells,  a statistically greater proportion 
(25%) of TCR1640 T cells show long term calcium signaling compared to polyclonal T cells 
(Fig. 3.2.7 D). Additionally, there was no significant difference between TCR1640 T cells and 
polyclonal T cells with short calcium signaling (<2min) and no calcium signaling (Fig. 3.2.7 D).  
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Figure 3.2.7 Analysis of calcium signaling in TCR1640 T cells and polyclonal T cells in the lamina propria. A. 
Representative cumulative calcium levels (ratio of YFP/CFP) in TCR1640 T cells and polyclonal T cells. Each 
dot represents a calcium level shown by a single cell in each time point. B. Percentage of high calcium signal 
in TCR1640 T cells and polyclonal T cells. C. Duration of calcium signaling in TCR1640 or polyclonal T cells. 
Each dot represents a duration of a calcium signaling event. D. Proportion of T cells with different calcium 
signaling duration in TCR1640 or polyclonal T cells. In A and C, cumulative results from 3 experiments are 
shown. In B and D, mean ± SEM from 3 independent experiments are shown. Statistical differences were 
analysed by independent sample T-test.  
 
Following the identification of continuous calcium signaling in MOG specific T cells in the 
lamina propria, the possibility that stimulation induces NFAT nuclear translocation was 
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investigated. Precise detection of the subcellular location of NFAT-GFP requires high 
resolution. Therefore, confocal imaging was performed instead of two-photon intravital 
imaging.  
 
Figure 3.2.8 A. A representative image of NFAT-GFP labelled 2D2 T cells in the lamina propria of ileum. 
Image on the left shows an overview of villi within the lamina propria, scale bar, 50 µm. Image on the right 
is a high magnification view of the villi, scale bar, 20 µm. Epithelial cells are shown in red by anti-Ep-CAM 
antibody, T cells are shown in green by NFAT-GFP. B. Analysis of nuclear translocation of NFAT-GFP labelled 
2D2 T cells in lamina propria of ileum. The graph contains 19 cells from 3 experiments 
 
MOG specific 2D2 T cells were transduced with NFAT-GFP sensor coding retrovirus and 
transferred to C57BL/6 mice. 3 Days later, the ileum of the recipient was fixed by 4% PFA 
and 20 µm cryosections were prepared. Epithelial cells were stained by anti-Ep-CAM 
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antibody in order to elucidate tissue structure and images were acquired by confocal 
microscopy. NFAT-GFP labelled MOG specific T cells in the lamina propria of the ileum did 
not show nuclear translocation (Fig. 3.2.8). In total, 19 NFAT-GFP labelled 2D2 T cells in the 
lamina propria of the ileum were imaged and analysed, of which none showed nuclear 
translocation in the lamina propria of ileum (Fig. 3.2.8 B). 
3.2.3 MOG Specific T Cells in the Peyer’s Patch of the Small Intestine 
As introduced in the previous context, Peyer’s patch is one of the most important immune 
organs in the small intestine. Therefore, calcium fluctuation of MOG specific T cells was also 
investigated there. Similarly to previous experiments in the lamina propria, Twitch2b 
labelled 2D2 T cells or polyclonal T cells from C57BL/6 mice were intravenously transferred 
to wildtype C57BL/6 mice. Intravital imaging of Peyer’s patch was performed 3 days after 
the adoptive transfer. 
The Peyer’s patch demonstrates a different level of background calcium signals from lamina 
propria. Therefore, the threshold ratio of YFP/CFP was redefined as 0.73 in Peyer’s patch--
which 95% of polyclonal T cells are below. No difference in calcium events was observed 
between 2D2 T cells and polyclonal T cells (Fig. 3.2.9). One Twitch2b labelled 2D2 T cell in 
the Peyer’s patch was shown as a representative example (Fig.3.2.9 A). Continuous calcium 
signaling lasting around 2 mins was observed, but the signaling was much shorter than the 
events detected in the lamina propria. FRET values from 2D2 T cells and polyclonal T cells 
were further plotted and analysed. The ratio values of YFP/CFP and the frequency of high 
calcium signals in 2D2 T cells were similar to polyclonal T cells (Fig. 3.2.9 B and C). High 
calcium signal was observed in around 5% of total calcium datasets in both 2D2 T cells and 
polyclonal T cells (Fig.3.2.9 C). This is fewer than that observed in the lamina propria of the 
ileum (Fig. 3.2.4 B and Fig. 3.2.7 B). In addition, the duration of calcium signaling was 
analysed in more detail by using 55 2D2 T cells and 99 polyclonal T cells in Peyer’s patch 
from 3 independent experiments (Fig.3.2.9 D). No significant difference was observed in the 
proportion of T cells across the tree categories of calcium signaling: long term, short term 
and no signaling (Fig. 3.2.9 D).  
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Figure 3.2.9 Calcium imaging and analysis of 2D2 T cells in the Peyer’s patch. A. Representative images of a 
2D2 T cell showing continuous calcium signaling lasting ~2 min. Dotted outlines in fluorescent overlay (left) 
and pseudocolour ratio images (right) indicate a cell of interest. Blood vessels are labelled in red with 
Rhodamine; T cells are labelled in blue/green with Twitch2b; Scale bar, 20 µm. B. Representative calcium 
signals (ratio of YFP/CFP) in 2D2 T cells and polyclonal T cells in Peyer’s patch from 3 experiments are shown 
by cumulative plot. C. Percentage of high calcium signal in 2D2 T cells and polyclonal T cells. D. Propotion of 
T cells with different calcium signaling duration in 2D2 or polyclonal T cells. In C and D, mean ± SEM from 3 
independent experiments are shown. Statistical differences were analysed by independent sample T-test. 
 
2D2 T cells transduced with the NFAT-GFP sensor were also imaged in the Peyer’s 3 days 
after cell transfer. Representative images of NFAT-GFP labelled 2D2 T cells in Peyer’s patch 
were shown in figure 3.2.10 A. 52 2D2 T cells in total were analysed in Peyer’s patch. 
However, no nuclear translocation of NFAT was observed (Fig. 3.2.10 B).  
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Figure 3.2.10 NFAT-GFP labelled 2D2 T cells in Peyer’s patch. A. Representative time lapse tracking of NFAT-
GFP labelled 2D2 T cells in the Peyer’s patch. Blood vessels are labelled in red with Rhodamine; 2D2 T cells 
are labelled in green with NFAT-GFP; Yellow is due to autofluorescent signal from Peyer’s patch. Scale bar: 
15 µm. B. Analysis of nuclear translocation of NFAT in 2D2 T cells in Peyer’s patch. The graph contains 52 
cells from 3 experiments 
 
3.3 Phenotypes of Encephalitogenic T Cells from the Mesenteric 
Lymph 
3.3.1 Th17 Cells Emigrated from the Mesenteric Lymph 
The persistent calcium signaling seen in 2D2 T cells suggests lamina propria specific 
stimulation. Therefore, MOG specific T cells in the efferent lymphatic vessel from 
mesenteric lymph nodes were probed to examine phenotypic changes due to stimulation in 
the lamina propria.  Lymphatic cannulation was performed to the efferent lymph vessel 
located upstream of the thoracic duct in order to obtain the T cells emigrating from 
intestine (Druzd, Matveeva et al. 2017). Cellular phenotype was assessed with emphasis on 
cellular markers known to influence CNS infiltration and inflammation. With the given 
antigen of interest, it is particularly intriguing to consider how GALT associated phenotypic 
changes in T cells may contribute to the pathogenesis of EAE.   
Nowadays, Th17 cells have been considered the most important driver in autoimmune 
disease. Therefore, IL17A expression was analysed in CD4+ cells. The T cells from 2D2 mice 
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were compared with those from wildtype mice.  2D2 T cells were further gated for 
expression of Vα3.2 and Vβ11, which is expressed on MOG specific transgenic T cells. In the 
lymph sample, 2D2 mice expressed a significantly higher percentage of Th17 cells compared 
with C57BL/6 mice (Fig. 3.3.1 A, B).  
 
Figure 3.3.1 Expression of IL17A in T cells emigrating from the mesenteric lymph. A. CD4+ T cells from 2D2 
mice and WT mice were evaluated by IL17A staining and analysed by flow cytometry. Representative flow 
cytometry plots from 3 experiments are shown. BC. Percentage (B) and concentration (C) of IL17A+CD4+ T 
cells from efferent mesenteric lymph of 2D2 and wildtype mice. D. Concentration of IL17A+CD4+ T cells in the 
blood of 2D2 and wildtype mice serves as a control for the cells obtained from the lymph vessel. 2D2 lymph 
sample: n=5; wildtype lymph sample: n=6; 2D2 blood sample: n=4; wildtype blood sample: n=6; Dataset was 
analysed by independent sample T-test. Values represent means ± SEM.  
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The concentration of IL17 producing T cells (Th17 cells) in the lymph sample was also 
analysed. By adding defined number of FITC-conjugated beads, the cell number in each 
sample can be quantified by flow cytometry. By considering the mixture as homogeneous, 
the actual number of cells in the defined volume of lymph sample could be quantified from 
the number of beads detected by flow cytometry. The concentration of Th17 cells in the 
lymph of 2D2 mice was 20 times higher than that found in the lymph of C57BL/6 mice (Fig. 
3.3.1 C). As a control, the concentration of Th17 cells in peripheral blood was analysed. 
There were very few Th17 cells in the blood and no significant difference between 2D2 mice 
and C57BL/6 mice (Fig. 3.3.1 D). 
3.3.2 Th1 Cells Efferent from the Mesenteric Lymph 
IFNγ−producing CD4+ T cells (Th1 cells) have been well characterized as another instigator of 
EAE (Pierson, Simmons et al. 2012). Adoptive transfer of in vitro differentiated Th1 cells is 
capable of inducing EAE (Baron, Madri et al. 1993). In addition, loss of T-bet, a transcription 
factor that controls the expression of IFNγ, has been found to contribute the resistance to 
EAE in mice (Bettelli, Sullivan et al. 2004). Therefore, Th1 cells were also quantified in the 
lymph of 2D2 mice and C57BL/6 mice.  
The concentration of Th1 cells in the lymph sample was determined as described previously 
for Th17 cells. Although no difference in the percentage was seen, the concentration of Th1 
cells in the lymph of 2D2 mice was 4 times higher than that of C57BL/6 mice (Fig. 3.3.2 A, B 
and C). In contrast, the concentration of Th1 cells in the blood was comparable between 
2D2 mice and C57BL/6 mice (Fig. 3.3.2 D). 
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Figure 3.3.2 IFNγ expressing in T cells emigrating from mesenteric lymph. A. CD4+ T cells from 2D2 T cells and 
polyclonal T cells were evaluated by IFNγ staining and analysed by flow cytometry. Representative flow 
cytometry plots from 3 experiments were shown. BC. Percentage (B) and concentration (C) of IFNγ+CD4+ T 
cells from efferent mesenteric lymph of 2D2 and C57BL/6 mice. D. Concentration of IFNγ+CD4+ T cells in the 
blood of 2D2 and wildtype mice serves as a control. 2D2 lymph sample: n=5; wildtype lymph sample: n=6; 
2D2 blood sample: n=4; wildtype blood sample: n=6; Dataset was analysed by independent sample T-test. 
Values represent means ± SEM.  
 
3.3.3 CD44+CD4+ T cells Efferent from the Mesenteric Lymph 
CD44 is a membrane receptor that recognizes osteopontin and hyaluronan (Aruffo, 
Stamenkovic et al. 1990, Ghazi-Visser, Laman et al. 2013). It has been found that CD44 is 
chronically elevated in the demyelinating lesions of MS patients (Soilu-Hanninen, Laaksonen 
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et al. 2005). Increased expression of CD44 in the T cells from peripheral blood was reported 
during the relapse phase of MS (Soilu-Hanninen, Laaksonen et al. 2005). EAE studies have 
provided further evidence supporting the role of CD44. Deletion of CD44 results in a 
reduction in severity of EAE (Guan, Nagarkatti et al. 2011). Application of anti-CD44 blocking 
antibody prevented the development of EAE induced by adoptive transfer of MBP specific T 
cells (Brocke, Piercy et al. 1999). The mechanism by which CD44 influences EAE 
pathogenesis may act through T helper cell survival, differentiation and/or adhesion (Guan, 
Nagarkatti et al. 2011). Therefore, in addition to analysing the number of Th1 and Th17 cells, 
CD44+CD4+ T cells were also investigated. 
Compared with wildtype mice, the lymph sample from 2D2 mice contained a similar 
frequency of CD44 expressing CD4+ T cells (Fig. 3.3.4 A and B). The proportion of CD44+ cells 
in the CD4+ T cell population reached 4% in both 2D2 mice and C57BL/6 mice (Fig. 3.3.3 B). 
However, the concentration of CD44+CD4+ T cells in the lymph sample from 2D2 mice and 
wildtype mice was different to the frequency pattern. The concentration of CD44+CD4+ T 
cells was quantified similarly to IL17A and IFNγ expression. The lymph sample from 2D2 
mice contained a three times greater number of CD4+CD44+ T cells than C57BL/6 mice (Fig. 
3.3.3 C). Again, blood was used as a control. Very few CD44+CD4+ T cells were detected in 
the blood of both 2D2 mice and wildtype mice and no significant difference was observed 
(Fig. 3.3.3 D).  
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Figure 3.3.3 Expression of CD44 in T cells emigrating from mesenteric lymph. A. CD4+ T cells from 2D2 T cells 
and polyclonal T cells were evaluated by CD44 staining and analysed by flow cytometry. Representative flow 
cytometry plots from 3 experiments are shown. BC. Percentage (B) and concentration (C) of CD44+ T cells 
from efferent mesenteric lymph of 2D2 and wildtype mice. D. Concentration of CD44+ T cells in the blood of 
2D2 and wildtype mice serves as a control. 2D2 lymph sample: n=5; wildtype lymph sample: n=6; 2D2 blood 
sample: n=4; wildtype blood sample: n=6; Dataset was analysed by independent sample T-test. Values 
represent means ± SEM.  
 
3.4 The Influence of Microbiota on Encephalitogenic T Cells 
After confirming the stimulation of MOG specific T cells, but not polyclonal T cells, in the 
lamina propria, naturally the next question was: what factors are responsible for this 
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stimulation? Previous studies have demonstrated that the intestinal microbiota exerts 
significant influence on T cell proliferation and differentiation in the GALT (Berer, Mues et al. 
2011). Through the use of germ free recipients, calcium fluctuations of MOG specific T cells 
were further investigated in the lamina propria. The germ free recipients in this experiment 
were C57BL/6 mice born and cultivated in germ free condition. 3 days before intravital 
imaging, recipients were imported to conventional condition and received an i.v. injection of 
Twitch 2b labelled 2D2 T cells. This protocol minimizes colonization of microbiota.   
 
*Figure legend see next page 
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Figure 3.4.1 Calcium imaging of 2D2 T cells in the lamina propria of germ free C57BL/6 mouse. A. A 
representative track of a 2D2 T cell in the lamina propria of germ free wildtype C57BL/6 mouse. Intracellular 
calcium fluctuation (red line) and velocity (blue line) of the cell is shown. The light grey shadow highlights 
the imaging frames where the T cell moves continuously without calcium signaling (stage 1). The dark grey 
shadow highlights the imaging frames where the T ell shows both a decrease in velocity and calcium 
signaling (stage 2). B. Images from intravital calcium imaging of the tracked 2D2 T cell from stage1 and 
stage2 as indicated in A. Fluorescent overlay (left) and pseudocolour ratio images (right) of the indicated cell 
are depicted. The white line shows the trajectory of the T cell. Blood vessels are labelled in red with 
Rhodamine; T cells are labelled in blue/green with Twitch2b; collagen fibers are in blue due to 
autofluorescent signal. Scale bar, 25 µm. 
 
A representative tracking of a 2D2 T cell in the lamina propria of a germ free mouse is 
shown in figure 3.4.1 A. In most of the recorded time (~35 min, indicated as stage 1), no 
calcium signaling was observed and the T cell continuously moved with a high velocity (Fig. 
3.4.1). Short calcium signaling (<1 min) only occurred in the cell concurrently with decreased 
velocity (Stage 2 in Fig. 3.4.1).  
Calcium levels in 2D2 T cells at each time point were recorded and compared between 
conventional and germ free recipients (Fig. 3.4.2 A). In the lamina propria of germ free 
recipients, the frequency of the high ratio values of YFP/CFP (>0.69) in 2D2 T cells is 1.1%, 
which was significantly lower than the frequency observed in conventional recipients (Fig. 
3.4.2 C). Additionally, motility of 2D2 T cells in lamina propria of germ free recipients was 
greater as shown by an increase in velocity (Fig. 3.4.2 B and D). Furthermore, compared with 
recipients in conventional conditions, 2D2 T cells in germ free recipients show less long term 
calcium signaling in the lamina propria (Fig. 3.4.3 B). Collectively, these results demonstrate 
the influence of commensal microbiota on the calcium based stimulation of MOG specific T 
cells in the lamina propria. 
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Figure 3.4.2 Calcium level and velocity of 2D2 T cells in the lamina propria of conventional and germ free 
recipients. A. Representative calcium levels (ratio of YFP/CFP) in 2D2 T cells of different groups from 3 
experiments were shown by cumulative plots. Each dot represented a calcium level shown by a single cell in 
each time point. The percentage of the ratio higher than 0.69 are indicated in the figure. B. Representative 
velocity of 2D2 T cells in conventional and germ free recipients from 3 experiments were shown by 
cumulative plots. The red bar represents the mean. Datasets of conventional group were from previous 
experiment (Fig. 3.2.4).  
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Figure 3.4.3 Calcium signaling of 2D2 T cells in the lamina propria of germ free recipients. A. Duration of 
calcium signaling shown in 2D2 T cells from conventional or germ free recipients. Each dot represents a 
duration of a calcium signaling event. Cumulative results from 3 experiments are shown. B. Proportion of 
2D2 T cells with different calcium signaling duration in conventional or germ free recipients. Mean ± SEM 
from 3 independent experiments are shown. Statistical differences were analysed by independent sample T-
test. Datasets of conventional group were from previous experiment (Fig. 3.2.5). 
 
3.5 The Mechanism of MOG Specific T cell Stimulation in Lamina 
Propria 
The calcium signaling of MOG specific T cells in the lamina propria could be triggered by 
TCR-antigen interaction or antigen-independent way (Revy, Sospedra et al. 2001). To 
investigate the mechanism by which MOG specific T cells are stimulated in the lamina 
propria, anti-MHC class II blocking antibody was applied to the recipients containing 
Twitch2b labelled TCR1640 T cells during the imaging period. Time projection images of 
TCR1640 T cells in the lamina propria show a change in calcium signaling following 
administration of anti-MHC class II blocking antibody (Fig. 3.5.1 A). The ratio values of 
YFP/CFP for TCR1640 T cells were collected before and after the administration of anti-MHC 
class II antibody (Fig. 3.5.1 B). The frequency of high calcium signal in the MOG specific T 
cells was reduced to half by the administration of anti-MHC class II blocking antibody (Fig. 
3.5.1 C) 
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Figure 3.5.1 Calcium signaling in TCR1640 T cells in the lamina propria before and after the application of 
anti-MHC class II blocking antibody. A. Representative time projection pictures of TCR1640 T cells in the 
lamina propria before and after the application of anti-MHC class II blocking antibody. Fluorescent overlay 
(left) and pseudocolour ratio images (right) are depicted. Blood vessels are labelled in red with Rhodamine; 
T cells are labelled in blue/green with Twitch2b; collagen fibers are labelled in blue due to autofluorescent 
signal. Scale bar, 20 µm. B. Representative cumulative plots show calcium levels (ratio of YFP/CFP) in 
TCR1640 T cells before and after the injection of anti-MHC class II antibody. Each dot represents a calcium 
level shown by a single cell in each time point. C. Frequency changes of calcium signaling by the 
administration of anti-MHC class II antibody. Data obtained from same animal (before and after injection) is 
paired. Results from 3 independent experiments are shown. Datasets of TCR1640 T cells without 
administration of anti-MHC class II blocking antibody were from previous experiment (Fig. 3.2.7) 
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The influence of anti-MHC class II blocking antibody on the duration of calcium signaling in 
TCR1640 T cells in the lamina propria was further analysed (Fig.3.5.2). Before injection of 
the blocking antibody, several TCR1640 T cells in the lamina propria showed continuous 
calcium signaling, some lasting more than 10 min (Fig.3.5.2 A). However, after injection of 
the anti-MHC class II blocking antibody, less continuous calcium signaling was observed in 
TCR1640 T cells and the length of calcium signaling was reduced (Fig.3.5.2 A).  
The proportion of TCR1640 T cells with long term calcium signaling (> 2 min) in the lamina 
propria reached to 27%, and was then significantly reduced by the administration of anti-
MHC class II blocking (Fig.3.5.2 B). However, anti-MHC class II blocking antibody did not 
exert any influence on the proportion of TCR1640 T cells with short calcium signaling or 
those that lacked calcium signaling (Fig.3.5.2 C).   
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Figure 3.5.2 A. Duration of calcium signaling in TCR1640 T cells in the lamina propria before and after the 
administration of anti-MHC class II antibody. Each cumulative plot represents the duration of each 
continuous calcium signaling. Each dot represents a duration of a calcium signaling event. B. The effect of 
anti-MHC class II blocking antibody on the T cells with long calcium signaling. Results from a mouse are 
paired. C. The influence of anti-MHC class II blocking antibody on the T cells with short calcium signaling and 
without calcium signaling. When a T cell shows calcium signaling multiple times during the recoding, each 
calcium signaling is counted. Proportion of T cells is calculated as: number of T cells with calcium 
events/total number of T cells. Dataset were analysed by paired T-test. Mean ± SEM from at least 3 animals 
per group are shown. Datasets of TCR1640 T cells without administration of anti-MHC class II blocking 
antibody were from previous experiment (Fig. 3.2.7) 
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3.6 Intravital Imaging of T cells in the Lamina Propria of the Colon 
In addition to the small intestine, intravital imaging of T cells was also performed in the 
lamina propria of the colon. The colon hosts a larger number of microbiota than the small 
intestine (Mowat and Agace 2014) and exerts a major influence on shaping immune 
homeostasis (Sarrabayrouse, Bossard et al. 2014). Therefore, it is another important 
environment to investigate the behaviour of MOG specific T cells. Intravital imaging of T 
cells was established in the lamina propria of the colon.  
Representative images of Twitch2b labelled polyclonal T cells in the lamina propria of the 
colon were shown in figure 3.6.1. Using the same imaging setup established with the small 
intestine, T cells in the colon can be filmed with a stable viewing frame. The tracking analysis 
of the indicated T cell in the image showed no calcium signaling and high velocity. 
 
Figure 3.6.1 Calcium imaging of polyclonal T cells in the lamina propria of colon. Fluorescent overlay (left) 
and pseudocolour ratio images (right) of the polyclonal T cell were depicted. White line shows the trajectory 
of the indicated T cell. Blood vessels are labelled in red with Rhodamine; T cells are labelled in blue/green 
with Twitch2b; collagen fibers are labelled in blue due to autofluorescent signal. Scale bar, 25 µm. The 
tracking curves of the T cell displayed the velocity (blue line) and the intracellular calcium signaling (red line).  
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3.7 Transduction of Cultured B Cells with Activation Sensor  
3.7.1 In vitro Expansion of B cells 
B cells can act as antigen presenting cells to stimulate T cells and T cells can support B cell 
maturation. Although very little is known about B cells in the intestine, B cells may play an 
important immunogenic role in the GALT. Therefore, it is important to integrate B cells in 
the study of stimulation of T cells in the GALT as trigger of EAE. To explore the behaviour of 
B cells in the GALT by two-photon microscopy, B cells were cultured in vitro with feeder cells 
that express CD40L on their surface and secret BAFF (Nojima, Haniuda et al. 2011). IL4 was 
added for first 3 days, followed by IL21 to induce B cell maturation. 4 days after starting the 
culture, these in-vitro-induced germinal centre B cells (iGBs) were harvested and 
phenotypically analysed by flow cytometry. Almost all of the cultured B cells expressed 
CD19 (Fig. 3.6.1). The proportion of IgG1 and Fas expressing B cells surpassed 95% whereas 
the proportion of IgM expressing B cells was only around 10% (Fig. 3.6.1). There are around 
7% cultured B cells expressing CD138 which indicates a small amount of Ig+ plasma cells (Fig. 
3.6.1).  
 
 
 
 
 
Figure 3.6.1 Representative flow cytometry analysis of B cell phenotypes 4 days after culture.  
 
3.6.2 Retroviral Transduction of B cells 
After culturing for 4 days, B cells proliferate nicely and can be efficiently transduced. The 
spin-down transduction with NFAT-GFP and Twitch2b sensor is performed. Transduction 
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efficiency was analysed by flow cytometry 24 hrs after the transduction. Cultured B cells 
could be successfully labelled by both Twitch2b and NFAT-GFP (Fig.3.6.2). 
 
Figure 3.6.2 Representative flow cytometry histograms confirming the retroviral transduction efficiency of 
Twitch2b and NFAT-GFP in T cells. 
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DISCUSSION 
4.1 Calcium Signaling of MOG Specific T Cells in LP 
In this study, two lineages of MOG specific T cells are examined as paradigms to study the 
stimulation of encephalitogenic T cells in the GALT as a possibly relevant scenario before 
onset of clinical EAE. Encephalitogenic T cells obtained from 2D2 are specific for MOG 
peptide 35-55 whereas encephalitogenic T cells obtained from TCR1640 mice present 
specificity for MOG peptide 92-106. Both 2D2 mice and TCR1640 mice develop spontaneous 
EAE, with an incidence rate of 4% in 2D2 mice and 80% in TCR1640 mice (Bettelli, Pagany et 
al. 2003, Pollinger, Krishnamoorthy et al. 2009). The current study focuses on the 
stimulation of encephalitogenic T cells in the GALT before the onset of EAE. To achieve this, 
2D2 and TCR1640 mice without appreciable EAE symptoms are used as donors of MOG 
specific T cells. MOG specific T cells are stimulated in vitro with anti-CD3/CD28 Abs to induce 
potent proliferation that allows for the efficient uptake of retrovirally delivered activation 
sensors. Antibody stimulation was used since it provides similar stimulation to both MOG 
specific T cells and polyclonal T cells. Labelled T cells were then adoptively transferred to 
recipients 4 days after stimulation and were subsequently imaged in vivo 3 days later. 
Importantly, at the time point of adoptive transfer, T cells did not show calcium activity. 
Therefore, the activation resulted from CD3/CD28 induced activation of T cells in vitro does 
not serve as a confounding variable for the intravital analysis of T cell behaviour in the GALT.  
The small intestine can be segmented into three regions, namely duodenum, jejunum and 
ileum. The duodenum and jejunum play a vital role in digestion. They contain relatively less 
and more simple microbial species, mainly Lactobacilli and Streptococci (Mowat and Agace 
2014). Although there are a large number of Th17 cells in the duodenum and jejunum, there 
is no evidence to suggest that these parts of the small intestine are involved in the 
pathogenesis of EAE/MS. Compared with the duodenum and jejunum, a large variety of 
immunological events related to autoimmune diseases have been reported in the ileum. 
Furthermore, the ileum is the region that contains highest density and diversity of luminal 
microbial cells in the small intestine (Sommer and Backhed 2013). During the establishment 
of T cell mediated experimental arthritis, the elimination of intestinal microbiota reduces 
the number of Th17 cells in the ileum. This effect has been shown to be due to the impaired 
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production of serum amyloid A (SAA) from epithelial cells, resulting in ameliorated disease 
(Rogier, Evans-Marin et al. 2017). SAA production requires ILC3s to secrete IL22, which 
depends on the expression of IL23R on the ILC3s (Sano, Huang et al. 2015). In addition, SFB, 
which induces robust IL17A production in RORγt+ T cells, is restricted to the terminal ileum 
(Sano, Huang et al. 2015). Taken together, these findings highlight the lamina propria of the 
ileum as a promising region to investigate the stimulation of MOG specific T cells by two-
photon microscopy.  
Compared with polyclonal T cells, both 2D2 and TCR1640 MOG specific T cells showed 
higher frequency and longer lasting calcium signaling in the lamina propria of the ileum (Fig. 
3.2.4 A and B, Fig. 3.2.5. Fig. 3.2.7). Continuous calcium signaling, which lasted longer than 2 
min, was observed in 20% of recorded MOG specific T cells, whereas it is barely detected in 
polyclonal T cells (Fig. 3.2.5). As shown in our previous publication, such continuous calcium 
signaling is induced in an antigen dependent manner (Kyratsous, Bauer et al. 2017). 
Therefore, the datasets created through intravital imaging in this study prompt the 
possibility that MOG specific T cells are stimulated in an antigen dependent manner in the 
lamina propria of the ileum. Indeed, administration of anti-MHC class II antibody diminished 
continuous calcium signaling (Fig. 3.5.2). In contrast, Twitch2b expressing MOG specific T 
cells in the Peyer’s patch rarely displayed continuous calcium signaling (Fig. 3.2.9). The 
reason for such regional differences in calcium signaling needs to be further investigated. As 
the stimulatory potential of APCs can be variable in different anatomical location, it is 
reasonable to apply transcriptome analysis to distinguish relevant APCs in Peyer’s patch and 
the lamina propria.  
In contrast to the long term calcium signaling which was seen mostly in MOG specific T cells, 
short lasting calcium signaling took place in both MOG specific and polyclonal T cells. The 
short lasting calcium spikes in Twitch sensor labelled T cells has already been reported in the 
spleen and spinal cord (Kyratsous, Bauer et al. 2017). This short lived calcium signaling exists 
under non-inflammatory conditions and is not strong enough to induce the NFAT 
translocation (Kyratsous, Bauer et al. 2017). This study further demonstrates that short 
lasting calcium signaling can be blocked, at least partially, by chemokine receptor 
antagonists. In addition, it is speculated that short lasting calcium signaling induces a 
migratory phenotype. Taking these results into consideration, it is tempting to believe that 
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short lasting calcium signaling seen in MOG specific T cells in the GALT are antigen 
independent. Indeed, the short calcium signaling is not effected by anti-MHC class II 
blocking antibody as shown in this study as well as Kyratsous et al. (Kyratsous, Bauer et al. 
2017). 
As observed in this study, sustained calcium signaling could persist from 2 mins to 24 mins in 
MOG specific T cells, which was much shorter than the sustained calcium signaling caused 
by immunization in other studies (Wei, Safrina et al. 2007). The difference can be explained 
by the quality and quantity of antigen presentation. In the lymph node, there are many 
professional APCs that are loaded with an excess amount of exogenous antigen provided by 
immunization. In the small intestine, APCs, including macrophages and DCs disseminate 
throughout the intestine but maintain distinct phenotypes and functions in various 
anatomical sites (Faria, Reis et al. 2017). Among them, macrophages expressing the 
fractalkine receptor (CX3CR1) constitute the majority of intestinal APCs whereas lymph 
node macrophages contain different subsets, such as CD169+CX3CR1+F4/80- subcapsular 
sinus macrophage, CD169-CX3CR1-F4/80+ medullary cord macrophage and etc.. Intestinal 
DCs comprise less than 10% of intestinal APCs and are characterized by high expression of 
CD11c and MHC class II, but lack of a high affinity IgG receptor FCγR1 (CD64). Intestinal DCs 
can further be divided into three subsets: CD103+CD11b+, CD103+CD11b- and CD103-CD11b+ 
(Bekiaris, Persson et al. 2014). Each subset contributes to intestinal immunological reactions 
in different ways. For instance, intestinal macrophages most efficiently sample soluble 
luminal proteins, but lamina propria DCs are not capable of this process (Schulz et al., 2009; 
Farache et al., 2013). The regulatory effects of intestinal DCs are associated with the 
metabolites of luminal bacteria. For example, capsular polysaccharides from bacteroides 
fragilis can interact directly with plasmacytoid DC, resulting in the expression of molecules 
against colitis via TLR-2 and stimulation of CD4+ T cells to release IL10 (Dasgupta, Erturk-
Hasdemir et al. 2014). Therefore, the miscellaneous APCs subsets and the multifarious 
luminal antigens lower the occurrence of antigen saturation, which may shorten the 
duration of calcium signaling in intestinal MOG specific T cells (Celli, Lemaitre et al. 2007, 
Kyratsous, Bauer et al. 2017).   
Continuous calcium signaling is associated with the proliferation and differentiation of T cell. 
Calcium influx can activate several intracellular signaling pathways, including the 
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serine/threonine phosphatase calcineurin and its target transcription factor NFAT, CaMK 
(calmodulin kinase) and its target CREB (cyclic AMP-responsive element-binding protein), 
MEF2 (myocyte enhancer factor 2) which is regulated by both of calcineurin and CaMK 
pathways, and NF-κB (Oh-hora 2009). Among them, the calcineurin-NFAT pathway has been 
best unravelled in terms of its downstream contributions to transcriptional effects. NFAT is 
composed of five transcription factors: NFAT1 (also known as NFATc2), NFAT2, NFAT3, 
NFAT4 and NFAT5 (Oh-hora 2009). The TCR dependent calcium influx can activate NFAT1, 
which is prominent in peripheral T cells and has been well known to play a crucial role 
during the differentiation of Th17 cell. The defect in NFAT1 nuclear translocation affects the 
activation of IL17A promoter, resulting in the diminished production of IL17A (Gomez-
Rodriguez, Sahu et al. 2009). Another study shows that the inhibition of calcineurin in naïve 
T cells during the Th17-polarized culturing causes a severe reduction of the IL17A+ 
population (Kim, Srikanth et al. 2014). Orai1-deficient T cells, which lack the CRAC channel, 
have impaired calcium signaling and can not differentiate into Th17 cells. However, 
transducing Orai1-deficient T cells with constitutively active mutant of NFAT can rescue the 
impairment of Th17 differentiation (Kim, Srikanth et al. 2014). Consistently with the in vitro 
data, inhibition of CRAC channel in vivo ameliorates active EAE by significantly reducing the 
IL17A+ T cell population (Schuhmann, Stegner et al. 2010, Kim, Srikanth et al. 2014). Taken 
together, both long lasting calcium signaling and NFAT nuclear translocation are critical 
steps in Th17 cell induction. Although continuous calcium signaling is capable of inducing 
NFAT nuclear translocation, this was not observed in MOG specific T cells in the lamina 
propria or Peyer’s patch (Fig. 3.2.8 and Fig. 3.2.10) (Kyratsous, Bauer et al. 2017). However, 
it can be speculated that long lasting calcium signaling observed in the T cells in the lamina 
propria of the ileum still influences their migratory phenotype. Indeed, the number of 
trafficking of MOG specific T cells in GALT efferent lymphatics was greater than that of 
polyclonal T cells (Fig. 3.3.1, Fig. 3.3.2 and Fig. 3.3.3).  
To identify if the stimulation of MOG specific T cells was antigen-dependent, anti-MHC class 
II blocking antibody was administrated intravenously to the recipients of MOG specific T 
cells during intravital imaging. This allows for the comparison of T cell calcium signaling 
before and after infusion of antibody in the same animal. Both frequency and duration of 
the calcium signaling were significantly decreased after the antibody administration, 
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although there was still a small proportion of MOG specific T cells that showed the brief and 
continuous calcium signaling (Fig.3.5.1 and Fig.3.5.2). This reduction suggests that the 
calcium signaling detected in MOG specific T cells in the lamina propria relies on TCR-
antigen/MHC interaction. As speculated, anti-MHC class II blocking antibody did not 
influence brief calcium signaling since these calcium events are considered to be antigen 
independent.   
Result similar to these has been observed in the previous study investigating Twitch sensor 
labelled encephalitogenic T cells in the spinal cord leptomeninges. The long term calcium 
signaling is reduced by the administration of MHC class II blocking antibody, whereas short 
lasting calcium signaling is unaffected. Thereby, the calcium signaling retained in this study 
after the administration of MHC class II blocking antibody can be due to the antigen 
independent mechanism shown in the previous study (Kyratsous, Bauer et al. 2017). In 
addition, it has been shown that short-lived interaction between T cells and DCs, which do 
not require MHC molecules-antigen complex, induce short lasting calcium signaling in vitro 
(Revy, Sospedra et al. 2001). As opposed to clinging to DCs, T cells continuously crawl across 
the DC surface, leading to infrequent and transient calcium oscillations that are shorter than 
those produced by antigen recognition (Montes, McIlroy et al. 1999, Gunzer, Schafer et al. 
2000). Notably, integrins and selectins can cause intracellular calcium signaling in 
lymphocytes. However, these signals may be too weak to be detected by the Twitch2b 
sensor (Weismann, Guse et al. 1997, Thestrup, Litzlbauer et al. 2014).  
In addition to investigating T cells in the ileum, this study also performs intravital imaging of 
T cells in the colon. The colon is the main region for the trillions of commensal bacteria that 
inhabit the gut (Mowat and Agace 2014). Compare with the ileum, Tregs are the dominant 
population of CD4+ T cells in the lamina propria of the colon (Maynard, Harrington et al. 
2007). Therefore, it is possible that MOG specific T cells are stimulated in the colon but then 
subsequently suppressed by colonic Tregs. They are probably not as well stimulated as in 
the small intestine. Further experiments need to be performed to conclude the stimulation 
of MOG specific T cells in the colon. 
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4.2 Influence of Microbiota on T cell Activation and EAE Incidence 
It has been shown that the transfer of human microbiota from MS patients increase the 
incidence of spontaneous EAE through reducing IL10 production in the peripheral blood of 
recipient mice (Berer, Gerdes et al. 2017). In another spontaneous EAE mouse model which 
harbours MBP specific T cells, oral treatment of antibiotics dramatically decreases the 
incidence of EAE. Furthermore, gut dysbiosis during the young adulthood of transgenic mice 
with MBP specific T cells triggers CNS inflammation by impairing the development of 
Foxp3+CD4+ T cells and expression of E3 ubiquitin ligase genes (Yadav, Boppana et al. 2017). 
Taken together, modification of microbiota influences EAE pathogenesis. However, the 
cellular mechanisms of these processes have not been well studied. This study was 
generated by the hypothesis that commensal microbiota stimulate encephalitogenic T cells 
in the GALT. Indeed, through performing intravital imaging, it was shown that 
encephalitogenic T cells were stimulated in the lamina propria (Fig. 3.2.5 and Fig. 3.2.7). 
Since MHC class II serves a crucial role during the stimulation of GALT T cells (Fig. 3.5.1 and 
Fig. 3.5.2), it is reasonable to believe that intestinal APCs capture antigens, such as 
endogenous MOG or metabolites that can mimic MOG peptides and introduce them to T 
cells. To evaluate the influence of endogenous MOG, intravital imaging of Twitch2b 
expressing MOG specific T cells in MOG deficient mice will be performed. If MOG specific T 
cells are still stimulated in the GALT of MOG deficient mice, this stimulation should be 
induced by MOG-like peptides. However, even if this is the case, it will be very difficult to 
identify the peptide since there are a huge amount of metabolites from microbiota in small 
intestine.  
Previously, studies have shown that the commensal microbiota can promote inflammatory T 
helper responses during EAE development (Ochoa-Reparaz, Mielcarz et al. 2009, Berer, 
Mues et al. 2011). To further study the functional role of microbiota in EAE incidence, 
microbiota from monozygotic twin pairs who are discordant for MS were transplanted into 
germ free TCR1640 mice. The mice colonized with microbiota from MS-affected siblings 
develop higher rate of EAE than those colonized with microbiota from the healthy control-
derived counterparts (Berer, Gerdes et al. 2017). Therefore, it is reasonable to hypothesize 
that gut microbiota aggravate the stimulation of encephalitogenic T cells in the GALT. In this 
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study, calcium signaling of MOG specific T cells (as an indication of T cell stimulation) was 
investigated in the lamina propria of animals imported from a germ free environment. 
Limited by experimental parameters, the germ free recipients were housed in conventional 
conditions for 3 days before intravital imaging – minimizing the colonization of microbiota 
compared with other conventional recipients. Consequently, the frequency of calcium 
signaling was diminished in MOG specific T cells in the lamina propria of these germ free 
recipients (Fig. 3.4.2 and Fig. 3.4.3). This study visualizes the influential role of the gut 
microbiome in the stimulation of encephalitogenic T cells.  
Although some commensal microbes may stimulate encephalitogenic T cells and induce 
clinical EAE, there are some bacteria strains that could ameliorate EAE through increasing 
the number of intestinal Tregs (Calvo-Barreiro, Eixarch et al. 2017). The incidence of PLP 91-
110 induced EAE is reduced in mice gavaged with human gut derived Prevotella histicola (P. 
histicola) (Mangalam, Shahi et al. 2017). Colonization with P. histicola increases Tregs and 
activates CD103+ DCs in the mesenteric lymph nodes, resulting in reduced CNS inflammation 
(Mangalam, Shahi et al. 2017). Oral administration of a Gram-negative microorganism 
named Escherichia coli strain Nissle 1917 can also reduce the severity of EAE. During the 
treatment, autoreactive T cells produce higher levels of IL10 and exhibit less infiltration into 
the CNS following EAE induction. In treated mice, the intestinal barrier is protected from the 
dysfunction correlated with EAE development (Secher, Kassem et al. 2017). It is possible 
that these microbial treatments induce immune tolerance by regulating the host-microbiota 
homeostasis and ameliorate CNS inflammation. Although the treatments discussed above 
may highlight the beginnings of promising therapeutic routes for MS, clinical trials still need 
to be performed.  
 
4.3 Phenotypes of T cells Emigrating from the GALT 
In this study, MOG specific T cells stimulation in the GALT may influence the 
differentiation/maturation of T cells. In order to investigate the effect of this stimulation, 
surface molecules and intracellular cytokines of the MOG specific T cell emigrating from 
mesenteric lymph nodes were determined.   
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Th17 cells, detected by expression of IL17A, were found in the efferent mesenteric lymph 
emigrating from GALT. Compared with wildtype mice, both the proportion and absolute 
number of Th17 cells were increased significantly in 2D2 mice that did not show any clinical 
sign of EAE (Fig.3.3.1 A, B and C). In a previous study, the dynamics of intestinal Th17 cell 
frequency have been found to increase before the onset of EAE but gradually reduced after 
onset (Haghikia, Jorg et al. 2015). These results suggest that intestinal Th17 cells migrate 
into the CNS via GALT efferent lymphatic vessel during the development of EAE but not after 
onset. In line with this, our results suggest that the migration of GALT stimulated T cells 
increases before EAE onset.  
Intestinal Th17 cells can be induced by different subsets of mononuclear phagocytes in the 
lamina propria in response to different situations (Stockinger and Omenetti 2017).  For 
example, the induction of SFB-specific Th17 cells is mediated by CX3CR1 positive 
macrophages, but not conventional CD103+ DC (Panea, Farkas et al. 2015). However, in the 
mice which develop spontaneous small intestine inflammation, both CD103+ and CD103- 
DCs instruct pathologic Th17 cells (Liang, Huang et al. 2016). It is still not clear whether 
there is a certain DC subset that activates MOG specific T cells to mediate this 
differentiation. In the future, transgenic mouse lineages with fluorescent labels for different 
APCs, such as CCR2-RFP, CD11c-YFP and CX1CR3-GFP, can be applied to intravital imaging to 
identify the partnership of MOG specific T cells in the small intestine. 
Furthermore, expression of IFNγ is analysed in the T cells migrating out of mesenteric lymph, 
since IFNγ producing Th1 cells can induce EAE. Although there was no difference in the 
frequency, the absolute number of IFNγ+CD4+ T cells was elevated in the efferent 
mesenteric lymph of 2D2 mice (Fig. 3.3.2 B and C). This was due to the increased number of 
CD4+ T cells in the efferent mesenteric lymph of 2D2 mice (data not shown), which 
suggested traffic of the lymphocytes in the small intestine was enhanced.  
In the GALT, production of IFNγ is instructed in by CD103-CD11+ and CD103+CD11b- DCs, but 
not CD103+CD11b+ DCs (Liang, Huang et al. 2016).  
Although proximal signals required for Th1 differentiation clearly differ from signals 
governing Th17 development, some CD4+ T cells in the MS lesion have an intermediate 
phenotype, expressing IFNγ and IL17A simultaneously (Dendrou, Fugger et al. 2015). In 
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addition, Th17 can switch to Th1 under inflammatory conditions in the presence of certain 
cytokines like IL23 (Bhaumik and Basu 2017). Therefore, besides the classical induction of 
Th1 cells, the possibility that intestinal Th17 cells convert to Th1 cells in the GALT is possible. 
A previous study has found that both Th17 and Th1 cells are enhanced in the lamina propria 
during the preclinical phase of EAE (Haghikia, Jorg et al. 2015).  
Additionally, the expression of CD44 on the T cells from the efferent mesenteric lymph of 
2D2 and wildtype mice was also investigated. The absolute number of CD44+CD4+ T cells 
was increased in the 2D2 mice (Fig.3.3.3 C). CD44 serves as a marker of antigen-experienced, 
activated T cells (Firan, Dhillon et al. 2006, Alvarez-Sanchez, Cruz-Chamorro et al. 2015). 
Therefore, increased CD44+CD4+ T cells in the mesenteric lymph of 2D2 mice reflect 
upregulated migration of activated antigen-dependent T cells from the GALT. Moreover, 
CD44 is also involved in T cell polarization during EAE. Deletion of CD44 in encephalitogenic 
T cells inhibits the Th1/Th17 polarization in an in vitro cell culture (Guan, Nagarkatti et al. 
2011). In addition, genetic depletion of CD44 impairs the Th1/Th17 polarization through 
altering the gut microbiome and ameliorates EAE (Chitrala, Guan et al. 2017). Furthermore, 
CD44 has an important role for adhesion and cell migration as described in section 1.3.4 and 
3.3.3 (DeGrendele, Estess et al. 1996, Guan, Nagarkatti et al. 2011). Therefore, increased 
CD44+CD4+ T cells might also be associated with the increase of Th1/Th17 cells that 
emigrate from the GALT. Taking into consideration the elevated number of Th17 cells, Th1 
cells and CD44+CD4+ cells in GALT efferent lymph, MOG specific T cells have already 
experienced differentiation or expansion in the GALT. Restricted to the existing techniques, 
it is difficult to monitor the fate of a stimulated T cell in vivo. That is, following stimulation it 
is challenging to track where an individual T cell goes and how it phenotypically changes. 
Although relating intestinal MOG specific T cells to the demyelination in CNS is still quite 
challenging, enhanced Th17 cells differentiation in the efferent mesenteric lymph implies 
the pathogenic risk of EAE exerted by T cell stimulation in the GALT.   
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organ T cells Administration 
Frequency of high 
Calcium signal  
(Mean ± SEM) (%) 
Propotion of T cells with 
long calcium signaling 
(Mean ± SEM) (%) 
Lamina 
propria 
  
2D2 - 10.9 ± 1.0 22.7 ± 3.8 
C57BL/6 - 1.3 ± 0.8 1.7 ± 1.7 
TCR1640  - 13.3 ± 0.3 24.0 ± 2.3 
TCR1640  Blocking MHC class II 5.9 ± 1.7 7.6 ± 3.8 
SJL/J - 8.0 ± 0.7 16.9 ± 0.6 
2D2 Germ free recipients   
Peyer’s patch 
2D2 - 5.4 ± 0.8 10.5 ± 4.9 
C57BL/6 - 5.0 ± 0.4 9.1 ± 4.0 
 
Table 4.3.1 Summary of calcium signaling shown by MOG specific T cells and polyclonal T cells 
in the ileum. 
 
Overall, by combining activation sensors and intravital imaging, this study visualizes the 
calcium signaling of MOG specific T cells in the ileum (Table 4.3.1). The stimulation of MOG 
specific T cells has been localized mainly to the lamina propria, not the Peyer’s patch. In 
addition to location specificity, this study illustrates that the stimulation of encephalitogenic 
T cells in the GALT depended on MHC class II mediated antigen presentation. Emigrating 
MOG specific T cells are phenotypically altered by stimulation in the GALT, and appear to 
show a pathogenic tendency towards autoimmune disease. Overall, these findings suggest 
the essential role of gut microbiota in the stimulation of encephalitogenic T cells, implicating 
the gut origin of experimental CNS autoimmunity. This study was focusing on the ileum, but 
also established intravital imaging in the colon. It would be interesting to further explore the 
behaviour of encephalitogenic T cells in the colon. Last but not least, the possibility that 
GALT stimulated encephalitogenic T cells subsequently migrate to the CNS needs to be 
carefully examined in order to extend our understanding of the induction and development 
of CNS autoimmunity. 
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APC Antigen Presenting Cell 
BBB Blood Brain Barrier 
CaM Calmodulin 
CD Cluster of Differentiation 
CFP Cyan Fluorescent Protein 
CNS Central Nervous System  
CRAC Calcium-Release-Activated Calcium 
DAG Diacylglycerol 
DC Dendritic Cell 
DMEM Dulbecco’s Modified Eagle Medium 
DMSO Dimethyl Sulfoxide 
EAE Experimental Autoimmune Encephalomyelitis 
EDTA Ethylenediaminetetraacetic Acid 
EH Eagle’s HEPES 
ER Endoplasmic Reticulum 
FACS Fluorescence-Activated Cell Sorting 
FOXP3 Forkhead Box Protein P3 
FRET Förster/Fluorescence Resonance Energy Transfer  
G proteins   GTP-binding proteins  
GALT Gut Associated Lymphoid Tissue 
GFP Green Fluorescent Protein 
GM-CSF Granulocyte Macrophage Colony Stimulating Factor 
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HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HLA Human Leukocyte Antigens 
IFNγ Interferon Gamma 
Ig Immunoglobulin 
IL Interleukin 
ILC Innate Lymphoid Cell 
i.v.   Intravenous 
iGB in-vitro-induced Germinal Centre B cell 
IP3 inositol-1,4,5-trisphosphate 
LP Lamina Propria 
MAG Myelin Associated Glycoprotein 
MBP Myelin Basic Protein  
MHC Major Histocompatibility Complex 
MOG Myelin Oligodendrocyte Glycoprotein 
MS Multiple Sclerosis 
NFAT Nuclear Factor of Activated T cells  
NF-κB   Nuclear Factor kappa B  
NS Not Significant 
PBS Phosphate Buffered Saline 
PCR Polymerase Chain Reaction 
pDC Plasmacytoid Dendritic Cell 
PFA Paraformaldehyde 
PLC Phospholipase C 
PLP Myelin Proteolipid Protein 
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PMA Phorbol 12-Myristate 13-Acetate 
PP Peyer’s Patch 
PPMS Primary Progressive Multiple Sclerosis 
RFP Red Fluorescent Protein 
RRMS Relapsing Remitting Multiple Sclerosis 
SFB Segmented Filamentous Bacteria 
SGK Serine/threonine-protein Linase 
SILT Solitary Isolated Lymphoid Tissue 
SP Spleen 
SPMS Secondary Progressive Multiple Sclerosis 
STIM1 Stromal Interaction Molecule 1 
TCM T Cell Medium 
TCR T Cell Receptor 
TGF Transforming Growth Factor 
Th T helper 
TnC Troponin C 
Treg T Regulatory Cell 
YFP Yellow Fluorescent Protein 
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